Transcription	O
of	O
a	O
minimal	B-DNA
promoter	I-DNA
from	O
the	O
NF-IL6	B-DNA
gene	I-DNA
is	O
regulated	O
by	O
CREB/ATF	B-protein
and	O
SP1	B-protein
proteins	I-protein
in	O
U937	B-cell_line
promonocytic	I-cell_line
cells	I-cell_line
.	O

NF-IL6	B-protein
is	O
an	O
important	O
transcriptional	O
regulator	O
of	O
genes	O
induced	O
in	O
activated	B-cell_type
monocytes/macrophages	I-cell_type
,	O
and	O
NF-IL6	B-protein
is	O
the	O
only	O
CCAAT/enhancer-binding	B-protein
protein	I-protein
(	I-protein
C/EBP	I-protein
)	I-protein
family	I-protein
member	O
whose	O
steady-state	O
mRNA	O
levels	O
increase	O
upon	O
activation	O
of	O
monocytes	B-cell_type
(	O
1	O
)	O
.	O

We	O
show	O
that	O
increased	O
transcription	O
of	O
the	O
NF-IL6	B-DNA
gene	I-DNA
is	O
responsible	O
,	O
at	O
least	O
in	O
part	O
,	O
for	O
induction	O
of	O
NF-IL6	B-RNA
mRNA	I-RNA
following	O
activation	O
of	O
U937	B-cell_line
promonocytic	I-cell_line
cells	I-cell_line
.	O

We	O
have	O
identified	O
a	O
104-bp	B-DNA
minimal	I-DNA
promoter	I-DNA
region	I-DNA
of	O
the	O
NF-IL6	B-DNA
gene	I-DNA
that	O
is	O
sufficient	O
for	O
basal	O
and	O
activation-dependent	O
induction	O
of	O
transcription	O
in	O
U937	B-cell_line
cells	I-cell_line
.	O

This	O
region	O
contains	O
binding	O
sites	O
for	O
the	O
cAMP	B-protein
response	I-protein
element-binding	I-protein
protein/activation	I-protein
transcription	I-protein
factor	I-protein
(	O
CREB/ATF	B-protein
)	O
and	O
Sp1	B-protein
families	O
of	O
transcription	B-protein
factors	I-protein
.	O

Each	O
site	O
is	O
functionally	O
important	O
and	O
contributes	O
independently	O
to	O
transcription	O
of	O
the	O
NF-IL6	B-DNA
gene	I-DNA
in	O
U937	B-cell_line
cells	I-cell_line
.	O

K	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
BioLegend®	NULL
#	NULL
s	NULL
me	NULL
Journal	NULL
of	NULL
Transcription	NULL
of	NULL
a	NULL
Minimal	NULL
Promoter	NULL
from	NULL
4D	NULL
Immunolo	NULL
gy	NULL
the	NULL
NF-IL6	NULL
Gene	NULL
Is	NULL
Regulated	NULL
by	NULL
CREB/ATF	NULL
and	NULL
SP1	NULL
Proteins	NULL
in	NULL
U937	NULL
Promonocytic	NULL
Cells	NULL
Allison	NULL
Berrier	NULL
,	NULL
Gerald	NULL
Siu	NULL
and	NULL
Kathryn	NULL
Calame	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:2267-2275	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/5/2267	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
50	NULL
articles	NULL
,	NULL
26	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/5/2267	NULL
full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Transcription	NULL
of	NULL
a	NULL
Minimal	NULL
Promoter	NULL
from	NULL
the	NULL
NF-IL6	NULL
Gene	NULL
Is	NULL
Regulated	NULL
by	NULL
CREB/ATF	NULL
and	NULL
SP1	NULL
Proteins	NULL
in	NULL
U937	NULL
Promonocytic	NULL
Cells	NULL
Allison	NULL
Berrier	NULL
,	NULL
``	NULL
Gerald	NULL
Siu	NULL
,	NULL
and	NULL
Kathryn	NULL
Calame®	NULL
NF-IL6	NULL
is	NULL
an	NULL
important	NULL
transcriptional	NULL
regulator	NULL
of	NULL
genes	NULL
induced	NULL
in	NULL
activated	NULL
monocytes/macrophages	NULL
,	NULL
and	NULL
NF-IL6	NULL
is	NULL
the	NULL
only	NULL
CCAAT/enhancer-binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
family	NULL
member	NULL
whose	NULL
steady-state	NULL
mRNA	NULL
levels	NULL
increase	NULL
upon	NULL
activation	NULL
of	NULL
monocytes	NULL
(	NULL
1	NULL
)	NULL
.	NULL

We	NULL
show	NULL
that	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
is	NULL
responsible	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
for	NULL
induction	NULL
of	NULL
NF-IL6	NULL
mRNA	NULL
following	NULL
activation	NULL
of	NULL
U937	NULL
promonocytic	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
a	NULL
104-bp	NULL
minimal	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
NF-ZL6	NULL
gene	NULL
that	NULL
is	NULL
sufficient	NULL
for	NULL
basal	NULL
and	NULL
activation-dependent	NULL
induction	NULL
of	NULL
transcription	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
cAMP	NULL
response	NULL
element-binding	NULL
protein/activation	NULL
transcription	NULL
factor	NULL
(	NULL
CREB/ATF	NULL
)	NULL
and	NULL
Sp1	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Each	NULL
site	NULL
is	NULL
functionally	NULL
important	NULL
and	NULL
contributes	NULL
independently	NULL
to	NULL
transcription	NULL
of	NULL
the	NULL
NF-ZL6	NULL
gene	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
:	NULL
2267-2275.	NULL
tor	NULL
in	NULL
monocytes	NULL
that	NULL
bound	NULL
an	NULL
IL-1	NULL
response	NULL
element	NULL
in	NULL
the	NULL
IL-6	NULL
promoter	NULL
(	NULL
2	NULL
)	NULL
.	NULL

NF-IL6	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
CCAAT/enhancer-binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
*	NULL
family	NULL
of	NULL
basic-leucine	NULL
zipper	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
as	NULL
dimers	NULL
to	NULL
a	NULL
consensus	NULL
C/EBP	NULL
site	NULL
(	NULL
TTNNGNAAN	NULL
)	NULL
.	NULL

NF-IL6	NULL
is	NULL
strongly	NULL
induced	NULL
upon	NULL
activation	NULL
of	NULL
monocytes	NULL
,	NULL
and	NULL
it	NULL
is	NULL
the	NULL
only	NULL
known	NULL
C/EBP	NULL
protein	NULL
induced	NULL
following	NULL
monocyte	NULL
activation	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
monocyte/	NULL
macrophages	NULL
,	NULL
NF-IL6	NULL
is	NULL
critical	NULL
for	NULL
activation-dependent	NULL
expression	NULL
of	NULL
numerous	NULL
cellular	NULL
and	NULL
viral	NULL
genes	NULL
.	NULL

Many	NULL
cellular	NULL
genes	NULL
expressed	NULL
in	NULL
activated	NULL
macrophages	NULL
,	NULL
including	NULL
IL-/B	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
macrophage	NULL
(	NULL
M	NULL
)	NULL
-CSF	NULL
,	NULL
TNF-a	NULL
,	NULL
granulocyte	NULL
(	NULL
G	NULL
)	NULL
-CSF	NULL
,	NULL
and	NULL
nitric	NULL
oxide	NULL
synthase	NULL
,	NULL
contain	NULL
functionally	NULL
important	NULL
C/EBP	NULL
sites	NULL
in	NULL
their	NULL
transcriptional	NULL
regulatory	NULL
regions	NULL
(	NULL
2-6	NULL
)	NULL
.	NULL

NF-IL6	NULL
is	NULL
also	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
latent	NULL
HIV-1	NULL
provirus	NULL
and	NULL
for	NULL
replication	NULL
of	NULL
HIV-1	NULL
in	NULL
monocytes/macrophages	NULL
(	NULL
1	NULL
,	NULL
7	NULL
)	NULL
.	NULL

The	NULL
biologic	NULL
importance	NULL
of	NULL
NE-IL6	NULL
in	NULL
macrophages	NULL
has	NULL
been	NULL
confirmed	NULL
by	NULL
gene	NULL
targeting	NULL
experiments	NULL
in	NULL
mice	NULL
.	NULL

NF-IL6	NULL
``	NULL
~	NULL
mice	NULL
have	NULL
impaired	NULL
macrophage	NULL
function	NULL
,	NULL
including	NULL
a	NULL
poor	NULL
response	NULL
to	NULL
bacterial	NULL
or	NULL
viral	NULL
pathogens	NULL
and	NULL
severely	NULL
defective	NULL
tumor	NULL
cytotox-icity	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Cytokine	NULL
production	NULL
by	NULL
macrophages	NULL
derived	NULL
from	NULL
NF-IL6	NULL
``	NULL
~	NULL
mice	NULL
is	NULL
abnormal	NULL
,	NULL
confirming	NULL
the	NULL
importance	NULL
of	NULL
NF-IL6	NULL
for	NULL
regulated	NULL
transcription	NULL
of	NULL
cytokine	NULL
genes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
spleno-megaly	NULL
due	NULL
to	NULL
B	NULL
cell	NULL
and	NULL
monocyte/macrophage	NULL
hyperplasia	NULL
is	NULL
T	NULL
he	NULL
NF-IL6	NULL
gene	NULL
was	NULL
first	NULL
identified	NULL
as	NULL
a	NULL
transcription	NULL
fac-	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
College	NULL
of	NULL
Physicians	NULL
and	NULL
Surgeons	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10032	NULL
Received	NULL
for	NULL
publication	NULL
October	NULL
16	NULL
,	NULL
1997	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
April	NULL
23	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
GM29361	NULL
and	NULL
Al40342	NULL
to	NULL
K.C	NULL
.	NULL

and	NULL
Grant	NULL
AI34925	NULL
to	NULL
G.S	NULL
.	NULL

2	NULL
Current	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Physiology	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
Albany	NULL
Medical	NULL
Col-lege	NULL
,	NULL
Albany	NULL
,	NULL
NY	NULL
12208	NULL
.	NULL

3	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Kathryn	NULL
Calame	NULL
,	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
Columbia	NULL
University	NULL
College	NULL
of	NULL
Physicians	NULL
and	NULL
Surgeons	NULL
,	NULL
701	NULL
West	NULL
168th	NULL
Street	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10032	NULL
.	NULL

*	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
C/EBP	NULL
,	NULL
CCAAT/enhancer-binding	NULL
protein	NULL
;	NULL
M-CSF	NULL
,	NULL
macrophage	NULL
CSF	NULL
;	NULL
CREB/ATF	NULL
,	NULL
cAMP	NULL
response	NULL
element-binding	NULL
protein/activation	NULL
transcription	NULL
factor	NULL
;	NULL
CRE	NULL
,	NULL
cAMP	NULL
response	NULL
element	NULL
;	NULL
AP-1	NULL
,	NULL
activator	NULL
protein-1	NULL
;	NULL
wt	NULL
,	NULL
wild	NULL
type	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
frequently	NULL
observed	NULL
in	NULL
older	NULL
NF-ZL6	NULL
``	NULL
~	NULL
mice	NULL
in	NULL
conjunction	NULL
with	NULL
elevations	NULL
in	NULL
the	NULL
serum	NULL
levels	NULL
of	NULL
IL-6	NULL
and	NULL
macrophage	NULL
(	NULL
M	NULL
)	NULL
-CSF	NULL
,	NULL
suggesting	NULL
that	NULL
some	NULL
biologic	NULL
functions	NULL
of	NULL
NF-IL6	NULL
in	NULL
vivo	NULL
are	NULL
not	NULL
completely	NULL
understood	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Although	NULL
NF-IL6	NULL
mRNA	NULL
is	NULL
expressed	NULL
in	NULL
many	NULL
tissues	NULL
,	NULL
its	NULL
expression	NULL
is	NULL
usually	NULL
tightly	NULL
regulated	NULL
by	NULL
cellular	NULL
activation	NULL
or	NULL
differentiation	NULL
.	NULL

Steady-state	NULL
NF-IL6	NULL
mRNA	NULL
levels	NULL
are	NULL
strongly	NULL
induced	NULL
following	NULL
activation	NULL
of	NULL
monocytes/macrophages	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
effectors	NULL
including	NULL
mitogens	NULL
and	NULL
cytokines	NULL
such	NULL
as	NULL
LPS	NULL
,	NULL
PMA	NULL
,	NULL
IL-1	NULL
,	NULL
and	NULL
IL-6	NULL
(	NULL
2	NULL
)	NULL
.	NULL

NF-IL6	NULL
is	NULL
induced	NULL
upon	NULL
activation	NULL
of	NULL
splenic	NULL
B	NULL
cells	NULL
by	NULL
the	NULL
polyclonal	NULL
B	NULL
cell	NULL
mitogen	NULL
LPS	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
adipocytes	NULL
,	NULL
NFE-IL6	NULL
mRNA	NULL
levels	NULL
decrease	NULL
during	NULL
terminal	NULL
differentiation	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
regulated	NULL
expression	NULL
of	NULL
NF-IL6	NULL
in	NULL
these	NULL
cell	NULL
lineages	NULL
is	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
NF-IL6	NULL
in	NULL
monocytes/macrophages	NULL
for	NULL
activation-dependent	NULL
regulation	NULL
of	NULL
cellular	NULL
genes	NULL
and	NULL
of	NULL
HIV-1	NULL
provirus	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
the	NULL
regulation	NULL
of	NULL
NF-IL6	NULL
mRNA	NULL
expression	NULL
in	NULL
monocytes/macrophages	NULL
.	NULL

As	NULL
a	NULL
model	NULL
,	NULL
we	NULL
have	NULL
utilized	NULL
the	NULL
U937	NULL
promonocytic	NULL
cell	NULL
line	NULL
that	NULL
can	NULL
be	NULL
activated	NULL
to	NULL
undergo	NULL
differentiation	NULL
by	NULL
treatment	NULL
with	NULL
LPS	NULL
and/or	NULL
PMA	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Our	NULL
studies	NULL
demonstrate	NULL
that	NULL
in	NULL
U937	NULL
cells	NULL
steady-state	NULL
levels	NULL
of	NULL
NF-IL6	NULL
mRNA	NULL
increase	NULL
following	NULL
cellular	NULL
activation	NULL
with	NULL
LPS	NULL
and	NULL
PMA	NULL
due	NULL
to	NULL
increased	NULL
transcription	NULL
initiation	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
NF-ZL6	NULL
promoter	NULL
showed	NULL
that	NULL
a	NULL
104-bp	NULL
region	NULL
was	NULL
sufficient	NULL
to	NULL
confer	NULL
strong	NULL
basal	NULL
and	NULL
PMA-responsive	NULL
promoter	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Within	NULL
this	NULL
region	NULL
,	NULL
binding	NULL
sites	NULL
for	NULL
CREB/ATF	NULL
and	NULL
Spl	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
were	NULL
identified	NULL
and	NULL
shown	NULL
to	NULL
be	NULL
functionally	NULL
important	NULL
for	NULL
promoter	NULL
activity	NULL
.	NULL

Finally	NULL
,	NULL
endogenous	NULL
CREB/ATF	NULL
proteins	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
for	NULL
maximal	NULL
NF-IL6	NULL
promoter	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Tissue	NULL
culture	NULL
The	NULL
promonocytic	NULL
U937	NULL
cell	NULL
line	NULL
was	NULL
purchased	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
,	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
gentamicin	NULL
.	NULL

LPS	NULL
(	NULL
Salmonella	NULL
typhi-murium	NULL
type	NULL
w	NULL
;	NULL
Difco	NULL
,	NULL
Detroit	NULL
,	NULL
MI	NULL
)	NULL
was	NULL
resuspended	NULL
at	NULL
10	NULL
mg/m	NULL
!	NULL

in	NULL
H	NULL
,	NULL
O	NULL
and	NULL
used	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
pg/ml	NULL
.	NULL

Phorbol-12-myristate	NULL
13-acetate	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemicals	NULL
(	NULL
catalog	NULL
number	NULL
P-8139	NULL
;	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
was	NULL
resuspended	NULL
at	NULL
1	NULL
mg/ml	NULL
in	NULL
DMSO	NULL
and	NULL
used	NULL
at	NULL
a	NULL
final	NULL
0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
2268	NULL
concentration	NULL
of	NULL
10	NULL
ng/ml	NULL
.	NULL

For	NULL
the	NULL
stimulations	NULL
,	NULL
U937	NULL
cells	NULL
were	NULL
plated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1	NULL
X	NULL
10°	NULL
cell/ml	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
or	NULL
PMA	NULL
.	NULL

Luciferase	NULL
assays	NULL
The	NULL
murine	NULL
NF-IL6	NULL
genomic	NULL
clone	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
V.	NULL
Poli	NULL
(	NULL
Istituto	NULL
Ricerche	NULL
di	NULL
Biologia	NULL
Moleculaire	NULL
,	NULL
Pomezia	NULL
,	NULL
Italy	NULL
)	NULL
.	NULL

The	NULL
16-kbp	NULL
genomic	NULL
DNA	NULL
Sau3A	NULL
fragment	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
A	NULL
EMBL3	NULL
.	NULL

An	NULL
Nco	NULL
!	NULL

fragment	NULL
containing	NULL
2	NULL
kbp	NULL
5°	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
and	NULL
125	NULL
bp	NULL
3	NULL
'	NULL
of	NULL
the	NULL
initiation	NULL
site	NULL
was	NULL
end-filled	NULL
and	NULL
blunt-end	NULL
cloned	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
p19luc	NULL
.	NULL

A	NULL
plasmid	NULL
containing	NULL
1	NULL
kbp	NULL
5	NULL
'	NULL
of	NULL
the	NULL
initiation	NULL
site	NULL
was	NULL
generated	NULL
by	NULL
digestion	NULL
of	NULL
the	NULL
2-kbp	NULL
luc	NULL
construct	NULL
with	NULL
HindIII	NULL
and	NULL
Avril	NULL
,	NULL
and	NULL
subsequently	NULL
end	NULL
filled	NULL
and	NULL
religated	NULL
.	NULL

The	NULL
HindIII	NULL
site	NULL
is	NULL
a	NULL
unique	NULL
restriction	NULL
enzyme	NULL
site	NULL
located	NULL
on	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
p19luc	NULL
cloning	NULL
polylinker	NULL
,	NULL
whereas	NULL
the	NULL
AvrI	NULL
site	NULL
is	NULL
located	NULL
approximately	NULL
1	NULL
kbp	NULL
upstream	NULL
of	NULL
the	NULL
start	NULL
site	NULL
of	NULL
NF-IL6	NULL
transcription	NULL
.	NULL

The	NULL
125-bp	NULL
NF-IL6	NULL
promoter	NULL
construct	NULL
was	NULL
prepared	NULL
by	NULL
digestion	NULL
of	NULL
the	NULL
2-kbp	NULL
luc	NULL
construct	NULL
with	NULL
HindIII	NULL
and	NULL
Smal	NULL
,	NULL
with	NULL
subsequent	NULL
end	NULL
fill	NULL
and	NULL
religation	NULL
.	NULL

The	NULL
125-bp	NULL
NF-IL6	NULL
promoter	NULL
plasmid	NULL
served	NULL
as	NULL
the	NULL
PCR	NULL
template	NULL
for	NULL
generation	NULL
of	NULL
the	NULL
-97	NULL
to	NULL
+72	NULL
,	NULL
-74	NULL
to	NULL
+72	NULL
,	NULL
-44	NULL
to	NULL
+72	NULL
.	NULL

The	NULL
primers	NULL
used	NULL
for	NULL
PCR	NULL
amplification	NULL
of	NULL
the	NULL
minimal	NULL
promoter	NULL
constructs	NULL
were	NULL
-97	NULL
AAG	NULL
GAAGCTTCGGGTGGCGGGG	NULL
-74	NULL
AAGGAAGCTTGCCCCAGCGT	NULL
GACG	NULL
-44	NULL
AAGGAAGCTTGCCGCCITTATAAAC	NULL
+72	NULL
GGAAAAGCT	NULL
TCCCAGGCCAGCA	NULL
.	NULL

The	NULL
construct	NULL
used	NULL
for	NULL
transfection	NULL
efficiency	NULL
control	NULL
contains	NULL
the	NULL
renilla	NULL
luciferase	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

The	NULL
site	NULL
I	NULL
mutant	NULL
-97	NULL
to	NULL
+72	NULL
NF-IL6	NULL
promoter	NULL
plasmid	NULL
containing	NULL
13	NULL
nucleotide	NULL
sequence	NULL
changes	NULL
in	NULL
a	NULL
15-bp	NULL
nucleotide	NULL
region	NULL
extending	NULL
from	NULL
-53	NULL
to	NULL
-67	NULL
was	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
firefly	NULL
luciferase	NULL
reporter	NULL
gene	NULL
through	NULL
mutagenic	NULL
PCR	NULL
using	NULL
the	NULL
Smal	NULL
construct	NULL
as	NULL
the	NULL
PCR	NULL
template	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
mutagenic	NULL
PCR	NULL
primer	NULL
is	NULL
as	NULL
follows	NULL
:	NULL
5°	NULL
AGGCGGCGCCTGGCACGCCGAGCTCCACCCCT	NULL
GGGGCCcccreecG	NULL
3	NULL
'	NULL
.	NULL

Nuclear	NULL
run-on	NULL
assay	NULL
For	NULL
the	NULL
nuclear	NULL
run-on	NULL
assay	NULL
,	NULL
U937	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LPS/PMA	NULL
or	NULL
media	NULL
alone	NULL
for	NULL
12	NULL
h.	NULL
Cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
set	NULL
aside	NULL
for	NULL
FACS	NULL
analysis	NULL
,	NULL
and	NULL
the	NULL
intensity	NULL
of	NULL
CD54	NULL
(	NULL
ICAM-1	NULL
)	NULL
staining	NULL
was	NULL
used	NULL
to	NULL
monitor	NULL
cellular	NULL
activation	NULL
.	NULL

The	NULL
nascent	NULL
RNA	NULL
transcripts	NULL
within	NULL
nuclei	NULL
prepared	NULL
from	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
elongated	NULL
in	NULL
vitro	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
radiolabeled	NULL
nucleotide	NULL
The	NULL
labeled	NULL
RNA	NULL
transcripts	NULL
were	NULL
isolated	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
approximately	NULL
1	NULL
%	NULL
10	NULL
``	NULL
cpm	NULL
of	NULL
nuclear	NULL
run-on	NULL
RNA	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
filter	NULL
onto	NULL
which	NULL
target	NULL
DNA	NULL
had	NULL
been	NULL
slotted	NULL
.	NULL

The	NULL
controls	NULL
used	NULL
in	NULL
this	NULL
study	NULL
included	NULL
murine	NULL
c-myc	NULL
and	NULL
glyceraldehyde	NULL
phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
.	NULL

The	NULL
washed	NULL
filter	NULL
was	NULL
air	NULL
dried	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
a	NULL
phosphorimager	NULL
screen	NULL
for	NULL
quantitation	NULL
of	NULL
the	NULL
signals	NULL
using	NULL
Molecular	NULL
Dynamics	NULL
(	NULL
Sunny-vale	NULL
,	NULL
CA	NULL
)	NULL
software	NULL
.	NULL

Transient	NULL
transfections	NULL
For	NULL
the	NULL
transient	NULL
transfection	NULL
assays	NULL
,	NULL
6	NULL
X	NULL
10°	NULL
U937	NULL
cells	NULL
in	NULL
0.3	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
and	NULL
10	NULL
%	NULL
FCS	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
a	NULL
Bio-Rad	NULL
gene	NULL
pulsar	NULL
set	NULL
at	NULL
240	NULL
V	NULL
,	NULL
960	NULL
uF	NULL
.	NULL

Twenty	NULL
micrograms	NULL
of	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
firefly	NULL
luciferase	NULL
reporter	NULL
construct	NULL
were	NULL
cotransfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
renilla	NULL
luciferase	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
as	NULL
a	NULL
transfection	NULL
efficiency	NULL
control	NULL
.	NULL

The	NULL
CREB-2	NULL
cotransfection	NULL
experiments	NULL
did	NULL
not	NULL
include	NULL
a	NULL
transfection	NULL
efficiency	NULL
control	NULL
because	NULL
TK	NULL
promoter	NULL
activity	NULL
is	NULL
responsive	NULL
to	NULL
CREB/ATF	NULL
family	NULL
members	NULL
(	NULL
15	NULL
)	NULL
.	NULL

For	NULL
the	NULL
CREB	NULL
cotransfection	NULL
experiments	NULL
,	NULL
the	NULL
luciferase	NULL
activities	NULL
were	NULL
corrected	NULL
for	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
protein	NULL
in	NULL
the	NULL
transfectant	NULL
cellular	NULL
extracts	NULL
.	NULL

Electroporated	NULL
cells	NULL
were	NULL
equally	NULL
divided	NULL
into	NULL
two	NULL
6-ml	NULL
cultures	NULL
containing	NULL
complete	NULL
RPMI	NULL
with	NULL
or	NULL
without	NULL
PMA	NULL
.	NULL

Twelve	NULL
to	NULL
sixteen	NULL
hours	NULL
following	NULL
electroporation	NULL
,	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
luciferase	NULL
activity	NULL
were	NULL
measured	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
the	NULL
renilla	NULL
luciferase	NULL
cotransfection	NULL
experiments	NULL
,	NULL
20A	NULL
of	NULL
the	NULL
transfectant	NULL
extract	NULL
prepared	NULL
from	NULL
non-PMA-treated	NULL
cultures	NULL
were	NULL
assayed	NULL
for	NULL
renilla	NULL
luciferase	NULL
activity	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Promega	NULL
Dual	NULL
Luciferase	NULL
Assay	NULL
Kit	NULL
)	NULL
.	NULL

Transcript	NULL
stability	NULL
studies	NULL
U937	NULL
cells	NULL
were	NULL
cultured	NULL
without	NULL
or	NULL
with	NULL
LPS	NULL
and	NULL
PMA	NULL
for	NULL
12	NULL
h.	NULL
At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
stimulation	NULL
period	NULL
,	NULL
cultures	NULL
of	NULL
control	NULL
and	NULL
activated	NULL
U937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
5	NULL
ug/ml	NULL
Actinomycin	NULL
D	NULL
for	NULL
variable	NULL
lengths	NULL
of	NULL
time	NULL
;	NULL
then	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Total	NULL
cellular	NULL
mRNA	NULL
levels	NULL
were	NULL
assessed	NULL
by	NULL
Northern	NULL
blot	NULL
.	NULL

For	NULL
the	NULL
Northern	NULL
analysis	NULL
,	NULL
40	NULL
pg	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
were	NULL
loaded	NULL
per	NULL
lane	NULL
in	NULL
the	NULL
1	NULL
%	NULL
agarose	NULL
formaldehyde	NULL
gel	NULL
according	NULL
to	NULL
the	NULL
protocol	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
.	NULL

DNA	NULL
probes	NULL
for	NULL
Northern	NULL
anal	NULL
REGULATION	NULL
OF	NULL
NF-IL6	NULL
IN	NULL
U937	NULL
CELLS	NULL
ysis	NULL
were	NULL
labeled	NULL
by	NULL
the	NULL
random	NULL
hexamer	NULL
priming	NULL
method	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
NF-IL6	NULL
hybridization	NULL
probe	NULL
was	NULL
a	NULL
Psfl-EcoRI	NULL
fragment	NULL
derived	NULL
from	NULL
the	NULL
pBlue	NULL
610	NULL
plasmid	NULL
containing	NULL
the	NULL
human	NULL
NF-ZL6	NULL
cDNA	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
S.	NULL
Akira	NULL
,	NULL
Hyogo	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Hyogo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

The	NULL
Northern	NULL
was	NULL
hybridized	NULL
with	NULL
the	NULL
NF-IL6	NULL
specific	NULL
probe	NULL
,	NULL
stripped	NULL
(	NULL
Amersham	NULL
protocol	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
and	NULL
then	NULL
rehybridized	NULL
with	NULL
a	NULL
probe	NULL
containing	NULL
sequences	NULL
of	NULL
the	NULL
2.0-kbp	NULL
human	NULL
B-actin	NULL
cDNA	NULL
to	NULL
control	NULL
for	NULL
equal	NULL
loading	NULL
of	NULL
RNA	NULL
per	NULL
lane	NULL
.	NULL

The	NULL
B-actin	NULL
sequences	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
pGhu-B-actin	NULL
construct	NULL
containing	NULL
a	NULL
human	NULL
B-actin	NULL
cDNA	NULL
in	NULL
the	NULL
pGEM3	NULL
vector	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
R.	NULL
Della-Favera	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

The	NULL
Northern	NULL
blot	NULL
signals	NULL
were	NULL
quantitated	NULL
using	NULL
a	NULL
phosphorimager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

The	NULL
RNA	NULL
signal	NULL
observed	NULL
at	NULL
the	NULL
10-min	NULL
time	NULL
point	NULL
was	NULL
normalized	NULL
to	NULL
100	NULL
%	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
signal	NULL
remaining	NULL
with	NULL
time	NULL
was	NULL
calculated	NULL
.	NULL

DNase	NULL
I	NULL
protection	NULL
assay	NULL
A	NULL
NotI-Nco	NULL
!	NULL

fragment	NULL
from	NULL
the	NULL
NF-IL6	NULL
gene	NULL
corresponding	NULL
to	NULL
-284	NULL
to	NULL
+125	NULL
bp	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
was	NULL
5	NULL
'	NULL
end	NULL
labeled	NULL
on	NULL
the	NULL
coding	NULL
or	NULL
noncoding	NULL
strand	NULL
and	NULL
subjected	NULL
to	NULL
DNase	NULL
I	NULL
footprinting	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Each	NULL
reaction	NULL
contained	NULL
approximately	NULL
50,000	NULL
cpm	NULL
of	NULL
5	NULL
'	NULL
end-labeled	NULL
DNA	NULL
that	NULL
was	NULL
subjected	NULL
to	NULL
limited	NULL
DNase	NULL
I	NULL
digestion	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
nuclear	NULL
factors	NULL
.	NULL

The	NULL
crude	NULL
nuclear	NULL
extracts	NULL
used	NULL
for	NULL
the	NULL
DNase	NULL
I	NULL
reaction	NULL
were	NULL
prepared	NULL
from	NULL
control	NULL
and	NULL
LPS/	NULL
PMA-activated	NULL
U937	NULL
cells	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
were	NULL
purified	NULL
by	NULL
ammonium	NULL
sulfate	NULL
fractionation	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Approximately	NULL
one	NULL
third	NULL
of	NULL
the	NULL
purified	NULL
DNase	NULL
I	NULL
reaction	NULL
products	NULL
were	NULL
resolved	NULL
on	NULL
an	NULL
8	NULL
%	NULL
polyacrylamide/8	NULL
M	NULL
urea	NULL
sequencing	NULL
gel	NULL
.	NULL

EMSAs	NULL
Nuclear	NULL
extracts	NULL
from	NULL
control	NULL
and	NULL
20	NULL
h	NULL
PMA-activated	NULL
U937	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Site	NULL
I	NULL
EMSAs	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
included	NULL
1.5	NULL
to	NULL
6.0	NULL
ug	NULL
crude	NULL
nuclear	NULL
extract	NULL
,	NULL
0.5	NULL
ug	NULL
sheared	NULL
herring	NULL
sperm	NULL
DNA	NULL
,	NULL
10	NULL
mM	NULL
HEPES-KOH	NULL
pH7.9	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
Tris	NULL
.	NULL

HCI	NULL
pH7.5	NULL
,	NULL
15	NULL
mM	NULL
EDTA	NULL
pH8.0	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
ZnSQ	NULL
,	NULL
,	NULL
and	NULL
4	NULL
X	NULL
10*	NULL
cpm	NULL
of	NULL
probe	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
and	NULL
then	NULL
loaded	NULL
directly	NULL
onto	NULL
a	NULL
4.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
electrophoresed	NULL
at	NULL
100	NULL
V	NULL
in	NULL
1	NULL
%	NULL
Tris	NULL
glycine	NULL
electrophoresis	NULL
buffer	NULL
(	NULL
190	NULL
mM	NULL
glycine	NULL
,	NULL
25	NULL
mM	NULL
Tris	NULL
.	NULL

HC	NULL
]	NULL
pH8.5	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
complexes	NULL
resolved	NULL
from	NULL
free	NULL
probe	NULL
on	NULL
the	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
were	NULL
dried	NULL
onto	NULL
Whatman	NULL
paper	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
overnight	NULL
.	NULL

For	NULL
the	NULL
compe-titions	NULL
,	NULL
cold	NULL
oligonucleotides	NULL
were	NULL
incubated	NULL
with	NULL
extract	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

In	NULL
the	NULL
supershift	NULL
experiments	NULL
,	NULL
Abs	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
and	NULL
incubated	NULL
for	NULL
40	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
before	NULL
addition	NULL
of	NULL
probe	NULL
.	NULL

The	NULL
CREB/ATF1	NULL
mAb	NULL
was	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnologies	NULL
(	NULL
catalog	NULL
number	NULL
sc-270	NULL
;	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
IgG1	NULL
Gag	NULL
Abs	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
D.	NULL
Wong	NULL
(	NULL
Columbia	NULL
University	NULL
)	NULL
.	NULL

Site	NULL
II	NULL
EMSAs	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
binding	NULL
conditions	NULL
elsewhere	NULL
described	NULL
(	NULL
see	NULL
Ref	NULL
.	NULL

28	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
complexes	NULL
were	NULL
resolved	NULL
from	NULL
the	NULL
free	NULL
probe	NULL
as	NULL
described	NULL
for	NULL
site	NULL
I	NULL
EMSA	NULL
.	NULL

For	NULL
site	NULL
II	NULL
supershift	NULL
experiments	NULL
,	NULL
the	NULL
Sp1	NULL
and	NULL
Sp3	NULL
Abs	NULL
were	NULL
added	NULL
to	NULL
the	NULL
cold	NULL
binding	NULL
reaction	NULL
for	NULL
15	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
probe	NULL
.	NULL

Results	NULL
Activation	NULL
of	NULL
U937	NULL
promonocytes	NULL
with	NULL
PMA	NULL
and	NULL
LPS	NULL
induces	NULL
NF-IL6	NULL
transcription	NULL
Steady-state	NULL
levels	NULL
of	NULL
NF-IL6	NULL
mRNA	NULL
are	NULL
induced	NULL
10-	NULL
to	NULL
15-fold	NULL
following	NULL
activation	NULL
of	NULL
promonocytes	NULL
with	NULL
cytokines	NULL
or	NULL
phorbol	NULL
esters	NULL
(	NULL
Ref	NULL
.	NULL

4	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
however	NULL
,	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
this	NULL
induction	NULL
is	NULL
not	NULL
known	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
determine	NULL
whether	NULL
increased	NULL
mRNA	NULL
stability	NULL
or	NULL
increased	NULL
transcription	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
activation-dependent	NULL
increase	NULL
in	NULL
steady-state	NULL
NF-IL6	NULL
mRNA	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
cellular	NULL
activation	NULL
alters	NULL
the	NULL
stability	NULL
of	NULL
NF-IL6	NULL
mRNA	NULL
,	NULL
the	NULL
half-life	NULL
of	NULL
NE-IL6	NULL
mRNA	NULL
was	NULL
measured	NULL
in	NULL
untreated	NULL
and	NULL
activated	NULL
U937	NULL
cells	NULL
following	NULL
treatment	NULL
with	NULL
actinomycin	NULL
D.	NULL
Figure	NULL
1A	NULL
shows	NULL
results	NULL
that	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

Although	NULL
activation	NULL
caused	NULL
a	NULL
14-fold	NULL
increase	NULL
in	NULL
absolute	NULL
levels	NULL
of	NULL
NF-IL6	NULL
mRNA	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
mRNA	NULL
degradation	NULL
was	NULL
similar	NULL
in	NULL
untreated	NULL
and	NULL
activated	NULL
U937	NULL
cells	NULL
,	NULL
and	NULL
NF-IL6	NULL
mRNA	NULL
stability	NULL
decreased	NULL
modestly	NULL
following	NULL
activation	NULL
.	NULL

Therefore	NULL
,	NULL
increased	NULL
stability	NULL
of	NULL
NE-IL6	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
Time	NULL
i	NULL
]	NULL
e	NULL
up	NULL
we	NULL
AP	NULL
aa	NULL
2269	NULL
Time	NULL
j	NULL
#	NULL
#	NULL
#	NULL
»	NULL
NF-IL6	NULL
g	NULL
a	NULL
'	NULL
‘	NULL
B-Actin	NULL
Untreated	NULL
+LPS/PMA	NULL
_	NULL
€	NULL
»	NULL
|	NULL
\	NULL
*	NULL
O	NULL
-	NULL
No	NULL
Activation	NULL
E	NULL
\	NULL
®	NULL
With	NULL
Activation	NULL
6	NULL
a	NULL
60	NULL
<	NULL
I	NULL
Z	NULL
CC	NULL
E	NULL
40	NULL
w	NULL
-=	NULL
!	NULL

the	NULL
zo	NULL
Z	NULL
Fo	NULL
Time	NULL
(	NULL
min	NULL
.	NULL
)	NULL

B	NULL
z	NULL
4	NULL
2	NULL
C	NULL
<	NULL
§	NULL
-	NULL
o	NULL
w	NULL
o	NULL
LPS/PMA	NULL
:	NULL
_	NULL
+	NULL
2	NULL
2	NULL
>	NULL
«	NULL
ame	NULL
wite	NULL
_	NULL
NF-IL6	NULL
E	NULL
oute	NULL
has	NULL
GAPDH	NULL
g	NULL
1	NULL
l	NULL
c-myc	NULL
t-	NULL
0	NULL
1	NULL
2	NULL
FIGURE	NULL
1	NULL
.	NULL

GAPDH	NULL
C-MYC	NULL
NF-IL6	NULL
Mitogen	NULL
activation	NULL
of	NULL
U937	NULL
cells	NULL
increases	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
.	NULL

A	NULL
,	NULL
Comparison	NULL
of	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
NF-IL6	NULL
mRNA	NULL
in	NULL
untreated	NULL
and	NULL
LPS/PMA-activated	NULL
U937	NULL
cells	NULL
.	NULL

Upper	NULL
panel	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
from	NULL
untreated	NULL
and	NULL
LPS/PMA	NULL
U937	NULL
cells	NULL
at	NULL
various	NULL
times	NULL
following	NULL
addition	NULL
of	NULL
actinomycin	NULL
D.	NULL
The	NULL
blot	NULL
was	NULL
hybridized	NULL
with	NULL
an	NULL
NF-ZL6-specific	NULL
probe	NULL
,	NULL
stripped	NULL
,	NULL
and	NULL
then	NULL
rehybridized	NULL
with	NULL
a	NULL
human	NULL
B-actin	NULL
probe	NULL
to	NULL
control	NULL
for	NULL
RNA	NULL
loading	NULL
.	NULL

Lower	NULL
panel	NULL
,	NULL
The	NULL
NF-IL6	NULL
transcripts	NULL
were	NULL
quantitated	NULL
with	NULL
a	NULL
phosphoImager	NULL
(	NULL
molecular	NULL
dynamics	NULL
software	NULL
)	NULL
and	NULL
normalized	NULL
to	NULL
B-Actin	NULL
.	NULL

B	NULL
,	NULL
Comparison	NULL
of	NULL
the	NULL
relative	NULL
rates	NULL
of	NULL
transcription	NULL
initiation	NULL
in	NULL
untreated	NULL
(	NULL
filter	NULL
1	NULL
)	NULL
and	NULL
12-h	NULL
LPS/PMA-activated	NULL
(	NULL
filter	NULL
2	NULL
)	NULL
U937	NULL
cells	NULL
.	NULL

Left	NULL
panel	NULL
shows	NULL
hybridization	NULL
of	NULL
labeled	NULL
RNA	NULL
to	NULL
specific	NULL
cDNAs	NULL
.	NULL

Right	NULL
panel	NULL
shows	NULL
a	NULL
graphic	NULL
representation	NULL
of	NULL
the	NULL
quantitated	NULL
results	NULL
.	NULL

This	NULL
experiment	NULL
was	NULL
performed	NULL
three	NULL
times	NULL
and	NULL
relative	NULL
rate	NULL
of	NULL
transcription	NULL
initiation	NULL
on	NULL
the	NULL
NF-ZL6	NULL
gene	NULL
increased	NULL
an	NULL
average	NULL
of	NULL
3.2	NULL
+	NULL
1.6-fold	NULL
.	NULL

mRNA	NULL
can	NULL
not	NULL
account	NULL
for	NULL
the	NULL
increase	NULL
in	NULL
steady-state	NULL
levels	NULL
observed	NULL
in	NULL
activated	NULL
U937	NULL
cells	NULL
.	NULL

Nuclear	NULL
run-on	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
measure	NULL
the	NULL
relative	NULL
rate	NULL
of	NULL
transcription	NULL
initiation	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
in	NULL
U937	NULL
cells	NULL
before	NULL
and	NULL
12	NULL
h	NULL
after	NULL
cellular	NULL
activation	NULL
with	NULL
PMA+LPS	NULL
.	NULL

Figure	NULL
1B	NULL
shows	NULL
a	NULL
representative	NULL
nuclear	NULL
run-on	NULL
experiment	NULL
where	NULL
the	NULL
rate	NULL
of	NULL
NF-IL6	NULL
transcription	NULL
initiation	NULL
was	NULL
induced	NULL
approximately	NULL
threefold	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
relative	NULL
rate	NULL
of	NULL
c-myc	NULL
transcription	NULL
was	NULL
examined	NULL
and	NULL
,	NULL
as	NULL
reported	NULL
previously	NULL
,	NULL
it	NULL
decreased	NULL
following	NULL
activation	NULL
of	NULL
the	NULL
U937	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
.	NULL

In	NULL
three	NULL
nuclear	NULL
run-on	NULL
experiments	NULL
,	NULL
an	NULL
average	NULL
increase	NULL
of	NULL
3.2	NULL
+	NULL
1.6-fold	NULL
in	NULL
the	NULL
relative	NULL
rate	NULL
of	NULL
NF-IL6	NULL
transcription	NULL
initiation	NULL
was	NULL
observed	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
NF-IL6	NULL
mRNA	NULL
observed	NULL
following	NULL
activation	NULL
of	NULL
U937	NULL
promonocytes	NULL
by	NULL
PMA+LPS	NULL
can	NULL
be	NULL
attributed	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
to	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

Two	NULL
promoter-proximal	NULL
regions	NULL
regulate	NULL
NF-IL6	NULL
gene	NULL
transcription	NULL
in	NULL
U937	NULL
promonocytes	NULL
Having	NULL
shown	NULL
that	NULL
the	NULL
relative	NULL
rate	NULL
of	NULL
NF-IL6	NULL
gene	NULL
transcription	NULL
initiation	NULL
is	NULL
increased	NULL
in	NULL
response	NULL
to	NULL
cellular	NULL
activation	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
identify	NULL
the	NULL
DNA	NULL
sequences	NULL
required	NULL
for	NULL
this	NULL
effect	NULL
.	NULL

The	NULL
transcription	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
was	NULL
mapped	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

First	NULL
we	NULL
tested	NULL
whether	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
NF-ZL6	NULL
gene	NULL
containing	NULL
the	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
conferred	NULL
activation-inducible	NULL
transcription	NULL
on	NULL
a	NULL
luciferase	NULL
reporter	NULL
.	NULL

Transient	NULL
transfections	NULL
were	NULL
conducted	NULL
in	NULL
U937	NULL
cells	NULL
using	NULL
a	NULL
luciferase	NULL
reporter	NULL
where	NULL
transcription	NULL
was	NULL
dependent	NULL
upon	NULL
a	NULL
fragment	NULL
of	NULL
the	NULL
NF-IZL6	NULL
gene	NULL
containing	NULL
2	NULL
kbp	NULL
5	NULL
'	NULL
and	NULL
125	NULL
bp	NULL
3	NULL
'	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

Following	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
divided	NULL
and	NULL
treated	NULL
with	NULL
various	NULL
combinations	NULL
of	NULL
activators	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
24	NULL
,	NULL
this	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
2270	NULL
7	NULL
-l	NULL
6	NULL
4	NULL
3	NULL
Fold	NULL
Activity	NULL
2	NULL
-l	NULL
9	NULL
None	NULL
_	NULL
LPS+	NULL
-	NULL
PMA	NULL
_	NULL
LPS	NULL
PMA	NULL
-1K	NULL
+125	NULL
JAL	NULL
REGULATION	NULL
OF	NULL
NF-IL6	NULL
IN	NULL
U937	NULL
CELLS	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
8	NULL
-	NULL
INF—ILG	NULL
00	NULL
10	NULL
2	NULL
30	NULL
40	NULL
50	NULL
60	NULL
7	NULL
+125	NULL
~	NULL
~	NULL
mmm	NULL
97	NULL
-	NULL
+72	NULL
/	NULL
-44	NULL
272	NULL
D	NULL
Untreated	NULL
W	NULL
rua	NULL
FIGURE	NULL
2	NULL
.	NULL

NF-IL6	NULL
promoter	NULL
activity	NULL
following	NULL
transfection	NULL
into	NULL
U937	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Activity	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
dependent	NULL
upon	NULL
a	NULL
fragment	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
(	NULL
-2	NULL
kbp	NULL
to	NULL
+125	NULL
bp	NULL
)	NULL
in	NULL
untreated	NULL
and	NULL
activated	NULL
U937	NULL
cells	NULL
.	NULL

Following	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
complete	NULL
media	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
the	NULL
combination	NULL
of	NULL
LPS	NULL
and	NULL
PMA	NULL
,	NULL
as	NULL
indicated	NULL
below	NULL
the	NULL
bar	NULL
graph	NULL
.	NULL

The	NULL
data	NULL
are	NULL
presented	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
in	NULL
untreated	NULL
cells	NULL
.	NULL

B	NULL
,	NULL
Defining	NULL
the	NULL
minimal	NULL
NF-IL6	NULL
promoter	NULL
.	NULL

Activity	NULL
of	NULL
different	NULL
portions	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
represented	NULL
schematically	NULL
on	NULL
the	NULL
Zeff	NULL
,	NULL
was	NULL
determined	NULL
in	NULL
untreated	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
and	NULL
PMA-treated	NULL
(	NULL
closed	NULL
bars	NULL
)	NULL
cells	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
-97-	NULL
to	NULL
+72-bp	NULL
NF-ZL6	NULL
construct	NULL
in	NULL
control	NULL
U937	NULL
cells	NULL
(	NULL
approximately	NULL
1-5	NULL
X	NULL
10°	NULL
light	NULL
units	NULL
)	NULL
was	NULL
set	NULL
to	NULL
1.0	NULL
.	NULL

These	NULL
data	NULL
represent	NULL
a	NULL
minimum	NULL
of	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

DNA	NULL
fragment	NULL
contains	NULL
promoter	NULL
and	NULL
transcriptional	NULL
regulatory	NULL
sequences	NULL
sufficient	NULL
to	NULL
confer	NULL
both	NULL
basal	NULL
and	NULL
activation-responsive	NULL
transcription	NULL
on	NULL
the	NULL
reporter	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
24	NULL
confirm	NULL
the	NULL
results	NULL
in	NULL
Figure	NULL
1	NULL
,	NULL
showing	NULL
that	NULL
transcription	NULL
from	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
increases	NULL
in	NULL
response	NULL
to	NULL
cellular	NULL
activation	NULL
by	NULL
PMA+LPS	NULL
.	NULL

Treatment	NULL
of	NULL
U937	NULL
cells	NULL
with	NULL
PMA	NULL
alone	NULL
or	NULL
PMA+LPS	NULL
had	NULL
a	NULL
similar	NULL
effect	NULL
,	NULL
inducing	NULL
transcription	NULL
five-	NULL
to	NULL
sixfold	NULL
;	NULL
however	NULL
,	NULL
treatment	NULL
with	NULL
LPS	NULL
alone	NULL
induced	NULL
transcription	NULL
minimally	NULL
(	NULL
1.6-fold	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
subsequent	NULL
transfections	NULL
,	NULL
PMA	NULL
alone	NULL
was	NULL
used	NULL
for	NULL
U937	NULL
cell	NULL
activation	NULL
,	NULL
and	NULL
our	NULL
studies	NULL
provide	NULL
insight	NULL
into	NULL
PMA-dependent	NULL
regulation	NULL
of	NULL
NF-ZL6	NULL
.	NULL

To	NULL
define	NULL
a	NULL
minimal	NULL
promoter	NULL
region	NULL
and	NULL
identify	NULL
regulatory	NULL
elements	NULL
required	NULL
for	NULL
NF-ZL6	NULL
promoter	NULL
activity	NULL
,	NULL
a	NULL
series	NULL
of	NULL
truncated	NULL
promoters	NULL
was	NULL
generated	NULL
and	NULL
transfected	NULL
into	NULL
U937	NULL
cells	NULL
.	NULL

Deleting	NULL
sequences	NULL
5	NULL
'	NULL
of	NULL
-97	NULL
bp	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
either	NULL
basal	NULL
or	NULL
activated	NULL
NF-ILG6	NULL
promoter	NULL
activity	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
region	NULL
from	NULL
-2	NULL
kb	NULL
to	NULL
-97	NULL
bp	NULL
is	NULL
not	NULL
required	NULL
for	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
3	NULL
'	NULL
truncation	NULL
to	NULL
+7	NULL
bp	NULL
did	NULL
not	NULL
alter	NULL
promoter	NULL
activity	NULL
.	NULL

Therefore	NULL
,	NULL
sequences	NULL
between	NULL
+7	NULL
and	NULL
+125	NULL
bp	NULL
are	NULL
not	NULL
required	NULL
for	NULL
promoter	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
5	NULL
'	NULL
truncation	NULL
to	NULL
-44	NULL
bp	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
reduction	NULL
in	NULL
NF-ZL6	NULL
promoter	NULL
activity	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
region	NULL
from	NULL
-97	NULL
to	NULL
+7	NULL
bp	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
basal	NULL
and	NULL
PMA-activated	NULL
promoter	NULL
activity	NULL
and	NULL
can	NULL
be	NULL
considered	NULL
the	NULL
minimal	NULL
NF-ZL6	NULL
promoter	NULL
in	NULL
this	NULL
assay	NULL
system	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
region	NULL
between	NULL
-97	NULL
to	NULL
-44	NULL
bp	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
promoter	NULL
activity	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

To	NULL
identify	NULL
protein-binding	NULL
sites	NULL
within	NULL
this	NULL
functionally	NULL
defined	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
,	NULL
DNase	NULL
I	NULL
footprinting	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
U937	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
DNase	NULL
I	NULL
protection	NULL
pattern	NULL
conferred	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
nuclear	NULL
factors	NULL
in	NULL
the	NULL
-44	NULL
to	NULL
-97-bp	NULL
region	NULL
on	NULL
both	NULL
the	NULL
coding	NULL
and	NULL
noncoding	NULL
strands	NULL
of	NULL
the	NULL
NF-IZL6	NULL
gene	NULL
is	NULL
shown	NULL
in	NULL
Figure	NULL
3A	NULL
.	NULL

Two	NULL
regions	NULL
of	NULL
protection	NULL
bracketed	NULL
by	NULL
hypersensitive	NULL
sites	NULL
were	NULL
observed	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
:	NULL
-34	NULL
to	NULL
-41	NULL
bp	NULL
,	NULL
which	NULL
encompasses	NULL
the	NULL
TATA	NULL
box	NULL
,	NULL
and	NULL
-48	NULL
to	NULL
-69	NULL
bp	NULL
,	NULL
which	NULL
we	NULL
will	NULL
refer	NULL
to	NULL
subsequently	NULL
as	NULL
site	NULL
I	NULL
.	NULL

On	NULL
the	NULL
noncoding	NULL
strand	NULL
,	NULL
a	NULL
region	NULL
corresponding	NULL
to	NULL
site	NULL
I	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
,	NULL
between	NULL
-55	NULL
to	NULL
-70	NULL
bp	NULL
,	NULL
was	NULL
protected	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
another	NULL
region	NULL
of	NULL
protection	NULL
between	NULL
-76	NULL
to	NULL
-82	NULL
bp	NULL
was	NULL
observed	NULL
only	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
,	NULL
and	NULL
this	NULL
region	NULL
is	NULL
designated	NULL
site	NULL
II	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
untreated	NULL
and	NULL
activated	NULL
U937	NULL
cells	NULL
gave	NULL
similar	NULL
patterns	NULL
of	NULL
protection	NULL
on	NULL
the	NULL
coding	NULL
and	NULL
noncoding	NULL
strands	NULL
(	NULL
Zanes	NULL
2	NULL
vs	NULL
3	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
footprinting	NULL
results	NULL
are	NULL
depicted	NULL
schematically	NULL
in	NULL
Figure	NULL
3B	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
sequences	NULL
of	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
with	NULL
known	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
revealed	NULL
that	NULL
site	NULL
I	NULL
contains	NULL
sequences	NULL
similar	NULL
to	NULL
a	NULL
CRE	NULL
or	NULL
AP-1	NULL
site	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Site	NULL
II	NULL
contains	NULL
a	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
Sp1	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
region	NULL
5	NULL
'	NULL
of	NULL
site	NULL
II	NULL
is	NULL
very	NULL
GC-rich	NULL
and	NULL
contains	NULL
additional	NULL
5	NULL
'	NULL
Spl	NULL
consensus	NULL
binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
protection	NULL
of	NULL
these	NULL
5	NULL
'	NULL
sequences	NULL
in	NULL
our	NULL
DNase	NULL
I	NULL
experiments	NULL
.	NULL

The	NULL
DNA	NULL
sequence	NULL
of	NULL
the	NULL
mouse	NULL
,	NULL
rat	NULL
,	NULL
and	NULL
human	NULL
NF-ZL6	NULL
promoter	NULL
region	NULL
is	NULL
shown	NULL
in	NULL
Figure	NULL
3C	NULL
.	NULL

The	NULL
regions	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
designated	NULL
as	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
are	NULL
indicated	NULL
with	NULL
a	NULL
box	NULL
in	NULL
Figure	NULL
3C	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
DNase	NULL
I	NULL
protected	NULL
regions	NULL
occur	NULL
within	NULL
sequences	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
,	NULL
which	NULL
are	NULL
highly	NULL
conserved	NULL
among	NULL
the	NULL
three	NULL
species	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
to	NULL
basal	NULL
NF-IL6	NULL
promoter	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
was	NULL
tested	NULL
by	NULL
a	NULL
transient	NULL
transfection	NULL
assay	NULL
.	NULL

A	NULL
promoter	NULL
lacking	NULL
both	NULL
site	NULL
I	NULL
and	NULL
site	NULL
II	NULL
(	NULL
-44	NULL
to	NULL
+72	NULL
bp	NULL
)	NULL
was	NULL
approximately	NULL
20-fold	NULL
less	NULL
active	NULL
than	NULL
the	NULL
-97-	NULL
to	NULL
+72-bp	NULL
promoter	NULL
containing	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
establishing	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
-97	NULL
to	NULL
-44-bp	NULL
region	NULL
for	NULL
NF-IL6	NULL
promoter	NULL
activity	NULL
.	NULL

A	NULL
promoter	NULL
lacking	NULL
site	NULL
II	NULL
but	NULL
retaining	NULL
site	NULL
I	NULL
(	NULL
-74	NULL
to	NULL
+72	NULL
bp	NULL
)	NULL
displays	NULL
modest	NULL
but	NULL
statistically	NULL
significant	NULL
reduction	NULL
in	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
-97	NULL
to	NULL
+72-bp	NULL
promoter	NULL
in	NULL
untreated	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
promoter	NULL
containing	NULL
wild-type	NULL
site	NULL
II	NULL
and	NULL
a	NULL
site-directed	NULL
mutation	NULL
that	NULL
alters	NULL
bases	NULL
-53	NULL
to	NULL
-67	NULL
in	NULL
site	NULL
I	NULL
(	NULL
mutI	NULL
-97	NULL
to	NULL
+72	NULL
bp	NULL
)	NULL
also	NULL
displays	NULL
a	NULL
modest	NULL
but	NULL
statistically	NULL
significant	NULL
reduction	NULL
in	NULL
activity	NULL
,	NULL
compared	NULL
with	NULL
the	NULL
promoter	NULL
containing	NULL
both	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
are	NULL
important	NULL
for	NULL
basal	NULL
NF-ZL6	NULL
promoter	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
to	NULL
activation-inducible	NULL
NF-IL6	NULL
promoter	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
was	NULL
also	NULL
determined	NULL
.	NULL

The	NULL
promoter	NULL
containing	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
is	NULL
reproducibly	NULL
induced	NULL
5.5-fold	NULL
by	NULL
activation	NULL
of	NULL
U937	NULL
cells	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
a	NULL
promoter	NULL
containing	NULL
only	NULL
site	NULL
I	NULL
(	NULL
-74	NULL
to	NULL
+72	NULL
bp	NULL
)	NULL
is	NULL
induced	NULL
4.2-fold	NULL
following	NULL
activation	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
a	NULL
promoter	NULL
containing	NULL
site	NULL
II	NULL
alone	NULL
(	NULL
mut	NULL
!	NULL

-97	NULL
to	NULL
+72	NULL
bp	NULL
)	NULL
is	NULL
induced	NULL
3.5-fold	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
.	NULL

Thus	NULL
both	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
are	NULL
necessary	NULL
for	NULL
full	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
,	NULL
but	NULL
they	NULL
do	NULL
not	NULL
function	NULL
synergistically	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
these	NULL
data	NULL
show	NULL
that	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
function	NULL
as	NULL
positive	NULL
regulatory	NULL
elements	NULL
for	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
in	NULL
U937	NULL
cells	NULL
and	NULL
that	NULL
they	NULL
are	NULL
independently	NULL
required	NULL
for	NULL
basal	NULL
and	NULL
-	NULL
activation-induced	NULL
transcription	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
2271	NULL
A	NULL
Coding	NULL
Non-coding	NULL
C	NULL
-97	NULL
-74	NULL
-44	NULL
Extract	NULL
:	NULL
-	NULL
U	NULL
OP	NULL
-	NULL
«	NULL
-	NULL
U	NULL
-	NULL
I	NULL
I	NULL
I	NULL
dis	NULL
«	NULL
o	NULL
``	NULL
ie	NULL
MOUSE	NULL
ceser	NULL
oscscaccaafmumsaskccc	NULL
ecoreacecaccccertece	NULL
Al	NULL
sece	NULL
al	NULL
«	NULL
an	NULL
~44	NULL
RAT	NULL
soc	NULL
s	NULL
ams	NULL
coe	NULL
-	NULL
«	NULL
G	NULL
KUMaN	NULL
eee	NULL
c	NULL
-	NULL
--	NULL
-s	NULL
to	NULL
mad	NULL
e	NULL
Up	NULL
«	NULL
--	NULL
Ch	NULL
-~44	NULL
z	NULL
m	NULL
aman	NULL
-	NULL
4-	NULL
&	NULL
.	NULL

fA	NULL
_	NULL
«	NULL
#	NULL
ase	NULL
-	NULL
%	NULL
Fis	NULL
fud	NULL
«	NULL
e	NULL
~43	NULL
+7	NULL
tte	NULL
use	NULL
-	NULL
wae	NULL
the	NULL
-	NULL
Cls	NULL
»	NULL
Cls	NULL
E	NULL
I	NULL
*	NULL
I	NULL
g	NULL
%	NULL
ea	NULL
MousE	NULL
|	NULL
coo	NULL
ComtATAMACTcCCG	NULL
ore	NULL
oe	NULL
ccocceccececcoemerccoemsccec	NULL
rae	NULL
Ne	NULL
Raz	NULL
A	NULL
HUMAN	NULL
¢	NULL
TAA	NULL
G	NULL
G	NULL
A	NULL
AGAAA	NULL
TTTA-	NULL
-	NULL
A	NULL
&	NULL
&	NULL
&	NULL
a	NULL
-+	NULL
u	NULL
ie	NULL
-74	NULL
dis	NULL
am	NULL
-	NULL
sas	NULL
dis	NULL
i	NULL
a	NULL
-74	NULL
g	NULL
«	NULL
wine	NULL
«	NULL
tine	NULL
a	NULL
9	NULL
in	NULL
-97	NULL
sous	NULL
wae	NULL
.	NULL

mates	NULL
dh	NULL
s	NULL
IL	NULL
din	NULL
--	NULL
me	NULL
us	NULL
-97	NULL
e	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
B	NULL
Site	NULL
II	NULL
Site	NULL
|	NULL
-9	NULL
-7|4	NULL
4	NULL
'	NULL
4	NULL
I	NULL
FIGURE	NULL
3	NULL
.	NULL

DNase	NULL
I	NULL
protection	NULL
analysis	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
.	NULL

A	NULL
,	NULL
The	NULL
NF-IL6	NULL
gene	NULL
coding	NULL
strand	NULL
was	NULL
5	NULL
``	NULL
labeled	NULL
at	NULL
-284	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
.	NULL

The	NULL
NF-IL6	NULL
gene	NULL
noncoding	NULL
strand	NULL
probe	NULL
was	NULL
5	NULL
'	NULL
labeled	NULL
at	NULL
+125	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
.	NULL

The	NULL
NF-IL6	NULL
coding	NULL
strand	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
and	NULL
noncoding	NULL
strand	NULL
(	NULL
Janes	NULL
5-7	NULL
)	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
0	NULL
(	NULL
Zanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
5	NULL
and	NULL
7	NULL
)	NULL
or	NULL
80	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
protein	NULL
prepared	NULL
from	NULL
untreated	NULL
(	NULL
Janes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
and	NULL
LPS/PMA-activated	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
U937	NULL
cells	NULL
before	NULL
the	NULL
limited	NULL
DNase	NULL
I	NULL
reaction	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
DNA	NULL
strand	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
,	NULL
designated	NULL
with	NULL
a	NULL
box	NULL
,	NULL
were	NULL
identified	NULL
by	NULL
alignment	NULL
with	NULL
parallel	NULL
lanes	NULL
of	NULL
a	NULL
dideoxynucleotide	NULL
sequencing	NULL
ladder	NULL
of	NULL
pUC19	NULL
.	NULL

Arrows	NULL
designate	NULL
sites	NULL
of	NULL
hypersensitivity	NULL
to	NULL
DNase	NULL
I	NULL
when	NULL
nuclear	NULL
proteins	NULL
were	NULL
present	NULL
.	NULL

The	NULL
image	NULL
of	NULL
the	NULL
noncoding	NULL
strand	NULL
gel	NULL
was	NULL
inverted	NULL
to	NULL
allow	NULL
a	NULL
direct	NULL
comparison	NULL
of	NULL
the	NULL
same	NULL
regions	NULL
on	NULL
both	NULL
strands	NULL
.	NULL

B	NULL
,	NULL
Sequence	NULL
of	NULL
the	NULL
NF-ZL6	NULL
gene	NULL
transcriptional	NULL
regulatory	NULL
region	NULL
with	NULL
nucleotide	NULL
positions	NULL
protected	NULL
in	NULL
the	NULL
DNase	NULL
I	NULL
reaction	NULL
shown	NULL
with	NULL
a	NULL
line	NULL
.	NULL

Vertical	NULL
arrows	NULL
designate	NULL
positions	NULL
of	NULL
hypersensitivity	NULL
detected	NULL
in	NULL
the	NULL
DNase	NULL
I	NULL
protection	NULL
assay	NULL
.	NULL

C	NULL
,	NULL
Sequence	NULL
of	NULL
the	NULL
murine	NULL
NF-IL6	NULL
gene	NULL
minimal	NULL
promoter	NULL
region	NULL
required	NULL
for	NULL
inducible	NULL
promoter	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Alignment	NULL
with	NULL
the	NULL
rat	NULL
and	NULL
human	NULL
minimal	NULL
NF-/L6	NULL
promoter	NULL
region	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
NF-ZL6	NULL
gene	NULL
designated	NULL
as	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
that	NULL
contain	NULL
the	NULL
DNase	NULL
I	NULL
protected	NULL
regions	NULL
are	NULL
framed	NULL
with	NULL
a	NULL
box	NULL
.	NULL

The	NULL
TATA	NULL
Box	NULL
,	NULL
CRE	NULL
or	NULL
AP-1	NULL
like	NULL
site	NULL
,	NULL
and	NULL
Spl	NULL
consensus	NULL
regions	NULL
are	NULL
underlined	NULL
.	NULL

The	NULL
horizontal	NULL
arrow	NULL
designates	NULL
the	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
.	NULL

The	NULL
dash	NULL
refers	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
corresponding	NULL
nucleotide	NULL
;	NULL
a	NULL
gap	NULL
indicates	NULL
the	NULL
insertion	NULL
of	NULL
a	NULL
nucleotide	NULL
.	NULL

CREB/ATF	NULL
and	NULL
Sp1	NULL
proteins	NULL
bind	NULL
to	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
in	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
EMSAs	NULL
were	NULL
performed	NULL
to	NULL
identify	NULL
proteins	NULL
from	NULL
U937	NULL
nuclei	NULL
that	NULL
bind	NULL
to	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
of	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
.	NULL

Table	NULL
I	NULL
contains	NULL
the	NULL
DNA	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
.	NULL

In	NULL
the	NULL
EMSA	NULL
shown	NULL
in	NULL
Figure	NULL
5A	NULL
,	NULL
a	NULL
site	NULL
I	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
PMA-activated	NULL
U937	NULL
cell	NULL
nuclear	NULL
proteins	NULL
.	NULL

One	NULL
prominent	NULL
complex	NULL
was	NULL
observed	NULL
that	NULL
was	NULL
competed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
20-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
site	NULL
I	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
,	NULL
lanes	NULL
9-11	NULL
)	NULL
but	NULL
not	NULL
by	NULL
an	NULL
80-fold	NULL
molar	NULL
excess	NULL
of	NULL
a	NULL
mutant	NULL
site	NULL
I	NULL
oligonucleotide	NULL
(	NULL
Zanes	NULL
12-14	NULL
)	NULL
.	NULL

An	NULL
unlabeled	NULL
consensus	NULL
CRE	NULL
site	NULL
oligonucleotide	NULL
(	NULL
Janes	NULL
6-8	NULL
)	NULL
competed	NULL
efficiently	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
site	NULL
I	NULL
probe	NULL
at	NULL
a	NULL
fivefold	NULL
molar	NULL
excess	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
consensus	NULL
AP-1	NULL
site	NULL
oligonucleotide	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
site	NULL
I	NULL
probe	NULL
at	NULL
an	NULL
80-fold	NULL
molar	NULL
excess	NULL
(	NULL
lanes	NULL
3-5	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
nuclear	NULL
factors	NULL
that	NULL
recognize	NULL
a	NULL
CRE	NULL
site	NULL
bind	NULL
to	NULL
site	NULL
IL	NULL
We	NULL
compared	NULL
the	NULL
binding	NULL
of	NULL
U937	NULL
nuclear	NULL
proteins	NULL
,	NULL
before	NULL
and	NULL
after	NULL
activation	NULL
,	NULL
to	NULL
oligonucleotide	NULL
probes	NULL
containing	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
AP-1	NULL
and	NULL
CRE	NULL
with	NULL
site	NULL
I	NULL
complexes	NULL
.	NULL

The	NULL
mobility	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
site	NULL
I	NULL
complex	NULL
before	NULL
and	NULL
after	NULL
activation	NULL
of	NULL
U937	NULL
cells	NULL
were	NULL
similar	NULL
to	NULL
the	NULL
CRE	NULL
consensus	NULL
probe	NULL
binding	NULL
activity	NULL
,	NULL
while	NULL
the	NULL
AP-1	NULL
consensus	NULL
probe	NULL
showed	NULL
a	NULL
retarded	NULL
complex	NULL
with	NULL
a	NULL
slower	NULL
mobility	NULL
.	NULL

This	NULL
result	NULL
also	NULL
suggests	NULL
that	NULL
CREB/ATF	NULL
family	NULL
proteins	NULL
bind	NULL
to	NULL
site	NULL
I	NULL
both	NULL
before	NULL
and	NULL
after	NULL
activation	NULL
.	NULL

To	NULL
test	NULL
directly	NULL
for	NULL
binding	NULL
of	NULL
ATE/CREB	NULL
proteins	NULL
to	NULL
site	NULL
I	NULL
,	NULL
a	NULL
mAb	NULL
that	NULL
recognizes	NULL
members	NULL
of	NULL
the	NULL
CREB/ATF	NULL
family	NULL
was	NULL
used	NULL
in	NULL
a	NULL
``	NULL
supershift	NULL
``	NULL
experiment	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
the	NULL
CREB/ATF	NULL
mAb	NULL
to	NULL
supershift	NULL
a	NULL
consensus	NULL
CRE	NULL
site	NULL
complex	NULL
was	NULL
examined	NULL
in	NULL
the	NULL
EMSA	NULL
binding	NULL
reactions	NULL
shown	NULL
in	NULL
Figure	NULL
5C	NULL
(	NULL
Zanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Nuclear	NULL
factors	NULL
that	NULL
recognize	NULL
the	NULL
site	NULL
I	NULL
probe	NULL
in	NULL
untreated	NULL
and	NULL
activated	NULL
U937	NULL
cells	NULL
were	NULL
supershifted	NULL
by	NULL
the	NULL
CREB/ATF	NULL
mAb	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
but	NULL
not	NULL
by	NULL
an	NULL
isotype-matched	NULL
control	NULL
mAb	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
site	NULL
I	NULL
complex	NULL
was	NULL
efficiently	NULL
supershifted	NULL
by	NULL
the	NULL
CREB/ATF	NULL
mAb	NULL
,	NULL
suggesting	NULL
that	NULL
most	NULL
site	NULL
I	NULL
complexes	NULL
contain	NULL
CREB/ATF	NULL
family	NULL
members	NULL
.	NULL

The	NULL
site	NULL
I	NULL
mutation	NULL
,	NULL
previously	NULL
shown	NULL
to	NULL
reduce	NULL
NF-ZL6	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
an	NULL
EMSA	NULL
that	NULL
revealed	NULL
that	NULL
the	NULL
site	NULL
I	NULL
mutation	NULL
ablates	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
that	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

51	NULL
,	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
,	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
members	NULL
of	NULL
the	NULL
CREB/ATF	NULL
family	NULL
bind	NULL
to	NULL
site	NULL
I	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
and	NULL
are	NULL
likely	NULL
to	NULL
mediate	NULL
site	NULL
I-dependent	NULL
transcriptional	NULL
activation	NULL
.	NULL

Analysis	NULL
of	NULL
U937	NULL
cell	NULL
nuclear	NULL
factors	NULL
that	NULL
recognize	NULL
the	NULL
NF-IL6	NULL
gene	NULL
site	NULL
II	NULL
region	NULL
is	NULL
shown	NULL
in	NULL
Figure	NULL
5K	NULL
.	NULL

In	NULL
the	NULL
EMSA	NULL
,	NULL
binding	NULL
reactions	NULL
performed	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
a	NULL
consensus	NULL
Spl	NULL
binding	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
p21	NULL
promoter	NULL
(	NULL
lanes	NULL
6-8	NULL
)	NULL
or	NULL
site	NULL
II	NULL
from	NULL
the	NULL
NF-IL6	NULL
gene	NULL
(	NULL
lanes	NULL
3-5	NULL
)	NULL
competed	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
U937	NULL
cell	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
site	NULL
II	NULL
probe	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutant	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
2272	NULL
REGULATION	NULL
OF	NULL
NF-IL6	NULL
IN	NULL
U937	NULL
CELLS	NULL
___	NULL
__	NULL
[	NULL
]	NULL
ema	NULL
-44	NULL
+72	NULL
_	NULL
.	NULL

Untreated	NULL
co	NULL
_I	NULL
_	NULL
-74	NULL
+72	NULL
4.2x	NULL
II	NULL
~	NULL
~97	NULL
+72	NULL
3.5	NULL
x	NULL
II	NULL
-	NULL
I	NULL
~	NULL
-97	NULL
+72	NULL
__—	NULL
5.5	NULL
%	NULL
U	NULL
T	NULL
*	NULL
I	NULL
U	NULL
J	NULL
U	NULL
I	NULL
U	NULL
o	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Site	NULL
I	NULL
and	NULL
site	NULL
II	NULL
are	NULL
required	NULL
for	NULL
activity	NULL
of	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
reporters	NULL
dependent	NULL
on	NULL
portions	NULL
of	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
.	NULL

The	NULL
length	NULL
and	NULL
content	NULL
of	NULL
the	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
NF-ZL6	NULL
promoter	NULL
in	NULL
the	NULL
panel	NULL
of	NULL
constructs	NULL
are	NULL
shown	NULL
schematically	NULL
at	NULL
the	NULL
Teff	NULL
.	NULL

The	NULL
bars	NULL
represent	NULL
the	NULL
relative	NULL
activity	NULL
in	NULL
untreated	NULL
(	NULL
solid	NULL
)	NULL
and	NULL
PMA-activated	NULL
(	NULL
open	NULL
)	NULL
U937	NULL
cells	NULL
after	NULL
normalization	NULL
to	NULL
a	NULL
control	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
-97-	NULL
to	NULL
+72-bp	NULL
NF-IL6	NULL
promoter	NULL
construct	NULL
in	NULL
untreated	NULL
U937	NULL
cells	NULL
was	NULL
set	NULL
to	NULL
1.0	NULL
.	NULL

The	NULL
values	NULL
shown	NULL
represent	NULL
the	NULL
average	NULL
of	NULL
at	NULL
least	NULL
five	NULL
independent	NULL
transfections	NULL
.	NULL

The	NULL
Student	NULL
?	NULL

test	NULL
for	NULL
variability	NULL
was	NULL
applied	NULL
to	NULL
results	NULL
comparing	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
-97	NULL
to	NULL
+72-bp	NULL
promoter	NULL
to	NULL
that	NULL
of	NULL
promoters	NULL
containing	NULL
-74	NULL
to	NULL
+72	NULL
bp	NULL
(	NULL
no	NULL
site	NULL
II	NULL
)	NULL
and	NULL
-97	NULL
to	NULL
+72	NULL
with	NULL
a	NULL
mutation	NULL
in	NULL
site	NULL
I	NULL
.	NULL

The	NULL
reduction	NULL
in	NULL
activity	NULL
of	NULL
the	NULL
latter	NULL
two	NULL
promoters	NULL
,	NULL
compared	NULL
with	NULL
the	NULL
-97	NULL
to	NULL
+72-bp	NULL
promoter	NULL
,	NULL
was	NULL
statistically	NULL
significant	NULL
(	NULL
p	NULL
=	NULL
0.01	NULL
)	NULL
.	NULL

Sp1	NULL
binding	NULL
site	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
site	NULL
II	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5E	NULL
,	NULL
lanes	NULL
9-11	NULL
)	NULL
(	NULL
28	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
directly	NULL
the	NULL
binding	NULL
of	NULL
Sp1	NULL
proteins	NULL
to	NULL
the	NULL
site	NULL
II	NULL
probe	NULL
,	NULL
antisera	NULL
that	NULL
recognize	NULL
Spl	NULL
or	NULL
Sp3	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reactions	NULL
.	NULL

Antiserum	NULL
that	NULL
recognizes	NULL
Sp1	NULL
supershifted	NULL
a	NULL
site	NULL
II	NULL
complex	NULL
formed	NULL
by	NULL
nuclear	NULL
factors	NULL
from	NULL
untreated	NULL
and	NULL
PMA-activated	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5F	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
preimmune	NULL
and	NULL
antiserum	NULL
that	NULL
recognizes	NULL
Sp3	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
binding	NULL
of	NULL
U937	NULL
cell	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
to	NULL
site	NULL
II	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
4	NULL
and	NULL
6	NULL
)	NULL
(	NULL
30	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
Spl	NULL
family	NULL
proteins	NULL
,	NULL
including	NULL
Sp1	NULL
but	NULL
not	NULL
Sp3	NULL
,	NULL
bind	NULL
site	NULL
II	NULL
in	NULL
the	NULL
NF-IL6	NULL
gene	NULL
and	NULL
are	NULL
likely	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
NF-IZL6	NULL
gene	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Table	NULL
I	NULL
.	NULL

-	NULL
The	NULL
sequence	NULL
of	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
EMSAs	NULL
Name	NULL
Sequence	NULL
wt	NULL
site	NULL
I	NULL
-44	NULL
to	NULL
-74	NULL
NF-IL6	NULL
promoter	NULL
GATCCCCCAGCGTGACGCAGCCCGTIGCC	NULL
GGGGTCGCACTGCGTCGGGCAACGGCTAG	NULL
-44	NULL
to	NULL
-74	NULL
mutant	NULL
NF-IL6	NULL
promoter	NULL
GATCCCCCAGGGGTGGAGCTCGGCGTIGCC	NULL
GGGGTCCCCACCTCGAGCCGCACGGCTAG	NULL
-74	NULL
to	NULL
-96	NULL
NF-IL6	NULL
promoter	NULL
GGGTGGCGGGGCGGCGGGaccc	NULL
CCCAcCcecccceccecccTeeee	NULL
-71	NULL
to	NULL
-86	NULL
p21	NULL
promoter	NULL
GGTCCCGCCTCCTIGA	NULL
CCAGGGCGGAGGAACT	NULL
-71	NULL
to	NULL
-86	NULL
mutant	NULL
p21	NULL
promoter	NULL
GGTCCCGGATCCTIGA	NULL
CCAGGGCCTAGGAACT	NULL
CRE	NULL
consensus	NULL
binding	NULL
site	NULL
GATCGTIGACGTICAGCGCG	NULL
CACTGCAGTCGCGCCTAG	NULL
AP-1	NULL
consensus	NULL
binding	NULL
site	NULL
GATCGTGACTCAGCGCG	NULL
CACTGAGTCGCGCCTAG	NULL
mut	NULL
site	NULL
I	NULL
Site	NULL
II	NULL
p2l	NULL
wt	NULL
p21	NULL
mut	NULL
CRE	NULL
AP-1	NULL
Endogenous	NULL
CREB/ATF	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
maximal	NULL
NF-IL6	NULL
promoter	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
Our	NULL
biochemical	NULL
studies	NULL
showed	NULL
that	NULL
CREB/ATF	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
in	NULL
U937	NULL
nuclear	NULL
extracts	NULL
bind	NULL
site	NULL
I	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
,	NULL
and	NULL
transient	NULL
transfections	NULL
indicated	NULL
that	NULL
site	NULL
I	NULL
is	NULL
functionally	NULL
important	NULL
for	NULL
promoter	NULL
activity	NULL
.	NULL

To	NULL
test	NULL
the	NULL
role	NULL
of	NULL
CREB/ATF	NULL
proteins	NULL
for	NULL
regulating	NULL
NF-IL6	NULL
promoter	NULL
activity	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
transient	NULL
cotransfection	NULL
assay	NULL
using	NULL
reporters	NULL
dependent	NULL
on	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
and	NULL
an	NULL
expression	NULL
plasmid	NULL
encoding	NULL
a	NULL
dominant	NULL
negative	NULL
form	NULL
of	NULL
CREB	NULL
,	NULL
CREB-2	NULL
.	NULL

CREB-2	NULL
exhibits	NULL
CRE	NULL
binding	NULL
activity	NULL
but	NULL
does	NULL
not	NULL
activate	NULL
transcription	NULL
due	NULL
to	NULL
changes	NULL
in	NULL
amino	NULL
acid	NULL
residues	NULL
of	NULL
the	NULL
kinase	NULL
inducible	NULL
domain	NULL
(	NULL
KID	NULL
)	NULL
domain	NULL
(	NULL
31	NULL
)	NULL
.	NULL

NF-ILG	NULL
promoter	NULL
activity	NULL
with	NULL
a	NULL
cotransfected	NULL
CREB-2	NULL
expression	NULL
plasmid	NULL
was	NULL
compared	NULL
with	NULL
promoter	NULL
activity	NULL
with	NULL
a	NULL
cotransfected	NULL
expression	NULL
plasmid	NULL
lacking	NULL
the	NULL
CREB-2	NULL
cDNA	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
the	NULL
CREB-2	NULL
cDNA	NULL
significantly	NULL
reduced	NULL
the	NULL
activity	NULL
of	NULL
NF-IL6	NULL
promoters	NULL
containing	NULL
an	NULL
upstream	NULL
CRE	NULL
site	NULL
(	NULL
site	NULL
I	NULL
)	NULL
in	NULL
untreated	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
1	NULL
vs	NULL
3	NULL
and	NULL
5	NULL
vs	NULL
7	NULL
)	NULL
and	NULL
in	NULL
PMA-activated	NULL
U937	NULL
cells	NULL
(	NULL
lanes	NULL
2	NULL
vs	NULL
4	NULL
and	NULL
6	NULL
vs	NULL
8	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
comparable	NULL
NF-ZL6	NULL
promoter	NULL
containing	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
CRE	NULL
site	NULL
,	NULL
mI	NULL
-97	NULL
to	NULL
+72	NULL
bp	NULL
,	NULL
was	NULL
only	NULL
slightly	NULL
reduced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
cotransfected	NULL
CREB-2	NULL
in	NULL
untreated	NULL
(	NULL
lanes	NULL
9	NULL
vs	NULL
11	NULL
)	NULL
or	NULL
PMA-activated	NULL
(	NULL
Zanes	NULL
10	NULL
vs	NULL
12	NULL
)	NULL
U937	NULL
cells	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
endogenous	NULL
CRE-binding	NULL
proteins	NULL
are	NULL
important	NULL
for	NULL
basal	NULL
and	NULL
PMA-inducible	NULL
NF-ZL6	NULL
promoter	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Discussion	NULL
We	NULL
have	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
U937	NULL
promonocytic	NULL
cells	NULL
leads	NULL
to	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
has	NULL
revealed	NULL
that	NULL
97	NULL
bp	NULL
5	NULL
'	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
both	NULL
basal	NULL
and	NULL
activation-induced	NULL
activity	NULL
in	NULL
this	NULL
system	NULL
.	NULL

Within	NULL
this	NULL
region	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
functionally	NULL
important	NULL
binding	NULL
sites	NULL
for	NULL
CREB/ATF	NULL
and	NULL
Spl	NULL
family	NULL
proteins	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
.	NULL

Site	NULL
1	NULL
Probe	NULL
Competitor	NULL
:	NULL
..|	NULL
ar-II	NULL
cre	NULL
wT	NULL
muUT	NULL
w	NULL
#	NULL
sp	NULL
.	NULL

complex	NULL
aw	NULL
12	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11121314	NULL
Probe	NULL
:	NULL
Site	NULL
1	NULL
B	NULL
.	NULL

Consensus	NULL
Site	NULL
Probes	NULL
u	NULL
P	NULL
U	NULL
P	NULL
UOP	NULL
P	NULL
Extract	NULL
:	NULL
#	NULL
sp	NULL
.	NULL

complex	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Probe	NULL
:	NULL
AP—	NULL
‘	NULL
llCRElﬂte	NULL
1	NULL
C.	NULL
Site	NULL
|	NULL
Super-shifts	NULL
Extract	NULL
:	NULL
s	NULL
u	NULL
U	NULL
P	NULL
Po	NULL
POP	NULL
U	NULL
U	NULL
U	NULL
Compatitof	NULL
:	NULL
L	NULL
a	NULL
&	NULL
&	NULL
&	NULL
<	NULL
<	NULL
&	NULL
WT	NULL
MUT	NULL
«	NULL
CREB	NULL
:	NULL
$	NULL
u	NULL
$	NULL
.	NULL

$	NULL
4	NULL
$	NULL
-~	NULL
abig	NULL
=	NULL
f	NULL
-	NULL
#	NULL
-	NULL
#	NULL
-	NULL
--	NULL
12	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
Probe	NULL
:	NULL
_	NULL
Site	NULL
1	NULL
-	NULL
CRE	NULL
Site	NULL
|	NULL
D.	NULL
Site	NULL
|	NULL
Probes	NULL
Extract	NULL
:	NULL
=	NULL
+-	NULL
+	NULL
#	NULL
#	NULL
<	NULL
sp	NULL
.	NULL

complex	NULL
1	NULL
2	NULL
3	NULL
%	NULL
Probe	NULL
:	NULL
Mut	NULL
WT	NULL
Site	NULL
|	NULL
E.	NULL
Site	NULL
II	NULL
Probe	NULL
Competitor	NULL
:	NULL
=	NULL
|	NULL
Site	NULL
I	NULL
|	NULL
pel	NULL
|pz1um	NULL
|_	NULL
w	NULL
'	NULL
rt	NULL
w	NULL
<	NULL
>	NULL
sp	NULL
.	NULL

complex	NULL
1	NULL
l	NULL
l	NULL
it	NULL
iL	NULL
4	NULL
123	NULL
4	NULL
§	NULL
607	NULL
8	NULL
9	NULL
101112	NULL
Probe	NULL
:	NULL
Site	NULL
.	NULL

II	NULL
F.	NULL
-	NULL
Site	NULL
II	NULL
Super-shifts	NULL
a§p1	NULL
=	NULL
#	NULL
-	NULL
-	NULL
+	NULL
a§p3	NULL
=	NULL
-	NULL
#	NULL
-	NULL
-	NULL
+	NULL
pre	NULL
+	NULL
ha	NULL
a	NULL
+	NULL
het	NULL
i	NULL
b-	NULL
<	NULL
€	NULL
d	NULL
tui	NULL
Guth	NULL
Soul	NULL
<	NULL
e	NULL
sp	NULL
.	NULL

complex	NULL
102	NULL
3	NULL
4	NULL
50	NULL
6	NULL
Probe	NULL
:	NULL
Site	NULL
|	NULL
FIGURE	NULL
5	NULL
.	NULL

Identification	NULL
of	NULL
proteins	NULL
in	NULL
U937	NULL
nuclear	NULL
extracts	NULL
that	NULL
bind	NULL
sites	NULL
I	NULL
and	NULL
II	NULL
.	NULL

A	NULL
,	NULL
Oligonucleotides	NULL
containing	NULL
sequences	NULL
derived	NULL
from	NULL
site	NULL
I	NULL
(	NULL
-44	NULL
to	NULL
-73	NULL
bp	NULL
)	NULL
of	NULL
the	NULL
wild-type	NULL
NF-IL6	NULL
gene	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
PMA-activated	NULL
U937	NULL
cells	NULL
.	NULL

Binding	NULL
to	NULL
the	NULL
site	NULL
I	NULL
probe	NULL
was	NULL
competed	NULL
with	NULL
5	NULL
%	NULL
(	NULL
Zanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
and	NULL
12	NULL
)	NULL
,	NULL
20	NULL
%	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
7	NULL
,	NULL
10	NULL
and	NULL
13	NULL
)	NULL
,	NULL
80	NULL
%	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
8	NULL
,	NULL
11	NULL
and	NULL
14	NULL
)	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
AP-1	NULL
(	NULL
lanes	NULL
3-5	NULL
)	NULL
,	NULL
CRE	NULL
(	NULL
lanes	NULL
6-8	NULL
)	NULL
,	NULL
site	NULL
I	NULL
(	NULL
lanes	NULL
9-11	NULL
)	NULL
,	NULL
and	NULL
mutant	NULL
site	NULL
I	NULL
(	NULL
lanes	NULL
12-14	NULL
)	NULL
oligonucleotides	NULL
described	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
performed	NULL
with	NULL
a	NULL
consensus	NULL
AP-1	NULL
site	NULL
(	NULL
Janes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
CRE	NULL
site	NULL
(	NULL
Janes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
and	NULL
wt	NULL
site	NULL
I	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
probes	NULL
incubated	NULL
with	NULL
6	NULL
ug	NULL
crude	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
2273	NULL
[	NULL
CI	NULL
Untreated	NULL
Relative	NULL
Activity	NULL
9	NULL
101112	NULL
-o-	NULL
4	NULL
+	NULL
CREB-2	NULL
-97	NULL
+72	NULL
-74	NULL
+72	NULL
-97	NULL
+72	NULL
FIGURE	NULL
6	NULL
.	NULL

A	NULL
transdominant	NULL
negative	NULL
CREB/ATF	NULL
family	NULL
member	NULL
,	NULL
CREB-2	NULL
,	NULL
reduces	NULL
NF-IL6	NULL
promoter	NULL
activity	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
panel	NULL
of	NULL
NF-IL6	NULL
promoter	NULL
constructs	NULL
driving	NULL
reporter	NULL
gene	NULL
expression	NULL
and	NULL
control	NULL
or	NULL
CREB-2	NULL
expression	NULL
plasmids	NULL
,	NULL
as	NULL
indicated	NULL
below	NULL
the	NULL
bar	NULL
graph	NULL
.	NULL

Following	NULL
electroporation	NULL
,	NULL
the	NULL
cotransfected	NULL
cells	NULL
were	NULL
equally	NULL
split	NULL
into	NULL
two	NULL
cultures	NULL
without	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
or	NULL
with	NULL
(	NULL
gray	NULL
bars	NULL
)	NULL
PMA	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
for	NULL
the	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
cell	NULL
extracts	NULL
.	NULL

The	NULL
reporter	NULL
activity	NULL
shown	NULL
for	NULL
each	NULL
construct	NULL
is	NULL
relative	NULL
to	NULL
the	NULL
reporter	NULL
activity	NULL
in	NULL
untreated	NULL
U937	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
control	NULL
expression	NULL
plasmid	NULL
.	NULL

The	NULL
constructs	NULL
used	NULL
in	NULL
this	NULL
experiment	NULL
include	NULL
wt	NULL
site	NULL
I	NULL
and	NULL
II	NULL
NF-IL6	NULL
promoter	NULL
construct	NULL
lanes	NULL
1-4	NULL
,	NULL
wt	NULL
site	NULL
I	NULL
NF-IL6	NULL
promoter	NULL
construct	NULL
lanes	NULL
5-8	NULL
,	NULL
mutant	NULL
site	NULL
I	NULL
and	NULL
wt	NULL
site	NULL
II	NULL
NF-IZL6	NULL
promoter	NULL
constructs	NULL
lanes	NULL
9-12	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
CRE	NULL
site	NULL
at	NULL
-62	NULL
bp	NULL
in	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
Our	NULL
studies	NULL
show	NULL
that	NULL
a	NULL
conserved	NULL
CRE	NULL
site	NULL
at	NULL
-62	NULL
bp	NULL
is	NULL
functionally	NULL
important	NULL
for	NULL
basal	NULL
and	NULL
PMA-inducible	NULL
NF-ZL6	NULL
promoter	NULL
untreated	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
and	NULL
5	NULL
)	NULL
and	NULL
PMA-activated	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
and	NULL
6	NULL
)	NULL
U937	NULL
cells	NULL
.	NULL

C	NULL
,	NULL
EMSA	NULL
supershift	NULL
performed	NULL
with	NULL
site	NULL
I	NULL
probe	NULL
(	NULL
Zanes	NULL
1-5	NULL
,	NULL
8-10	NULL
)	NULL
or	NULL
a	NULL
consensus	NULL
CRE	NULL
probe	NULL
(	NULL
Zanes	NULL
6-7	NULL
)	NULL
incubated	NULL
without	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
with	NULL
crude	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
untreated	NULL
(	NULL
Zanes	NULL
2	NULL
,	NULL
3	NULL
and	NULL
8-10	NULL
)	NULL
and	NULL
PMA-activated	NULL
(	NULL
lanes	NULL
4-7	NULL
)	NULL
U937	NULL
cells	NULL
.	NULL

eCREB/ATF	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
and	NULL
7	NULL
)	NULL
or	NULL
isotype-matched	NULL
control	NULL
«	NULL
Gag	NULL
(	NULL
Zanes	NULL
2	NULL
,	NULL
4	NULL
and	NULL
6	NULL
)	NULL
mAbs	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reactions	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
site	NULL
I	NULL
complexes	NULL
were	NULL
confirmed	NULL
by	NULL
competitions	NULL
with	NULL
wt	NULL
(	NULL
Zane	NULL
9	NULL
)	NULL
and	NULL
mutant	NULL
site	NULL
I	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
oligo-nucleotides	NULL
.	NULL

Controls	NULL
containing	NULL
probe	NULL
and	NULL
«	NULL
Gag	NULL
showed	NULL
no	NULL
bands	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
D	NULL
,	NULL
EMSA	NULL
performed	NULL
with	NULL
1	NULL
ng	NULL
end-labeled	NULL
wt	NULL
site	NULL
I	NULL
(	NULL
Zanes	NULL
3	NULL
,	NULL
4	NULL
)	NULL
and	NULL
mutant	NULL
site	NULL
I	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
)	NULL
probes	NULL
incubated	NULL
without	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
)	NULL
or	NULL
with	NULL
6	NULL
ug	NULL
PMA-activated	NULL
U937	NULL
cell	NULL
crude	NULL
nuclear	NULL
extract	NULL
(	NULL
Zanes	NULL
2	NULL
,	NULL
4	NULL
)	NULL
.	NULL

E	NULL
,	NULL
Oligonucleotides	NULL
containing	NULL
sequences	NULL
derived	NULL
from	NULL
site	NULL
II	NULL
(	NULL
-74	NULL
to	NULL
-96	NULL
bp	NULL
)	NULL
of	NULL
the	NULL
NF-ZL6	NULL
gene	NULL
were	NULL
end	NULL
labeled	NULL
and	NULL
incubated	NULL
without	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
with	NULL
(	NULL
lanes	NULL
2-12	NULL
)	NULL
6	NULL
pg	NULL
U937	NULL
cell	NULL
crude	NULL
nuclear	NULL
extract	NULL
.	NULL

Binding	NULL
to	NULL
the	NULL
site	NULL
II	NULL
probe	NULL
was	NULL
competed	NULL
with	NULL
50	NULL
%	NULL
(	NULL
Zanes	NULL
3	NULL
,	NULL
6	NULL
and	NULL
9	NULL
)	NULL
,	NULL
200	NULL
%	NULL
(	NULL
Zanes	NULL
4	NULL
,	NULL
7	NULL
and	NULL
10	NULL
)	NULL
and	NULL
800	NULL
%	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
8	NULL
and	NULL
11	NULL
)	NULL
molar	NULL
excess	NULL
of	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
NF-IL6	NULL
site	NULL
II	NULL
(	NULL
lanes	NULL
3-5	NULL
)	NULL
,	NULL
the	NULL
Sp1	NULL
site	NULL
from	NULL
the	NULL
p21	NULL
promoter	NULL
(	NULL
lanes	NULL
6-8	NULL
)	NULL
,	NULL
and	NULL
a	NULL
mutant	NULL
Sp1	NULL
site	NULL
from	NULL
the	NULL
p21	NULL
promoter	NULL
(	NULL
lanes	NULL
9-11	NULL
)	NULL
.	NULL

F	NULL
,	NULL
EMSA	NULL
supershift	NULL
performed	NULL
with	NULL
end-labeled	NULL
site	NULL
II	NULL
probe	NULL
incubated	NULL
with	NULL
crude	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
untreated	NULL
(	NULL
Zanes	NULL
1-3	NULL
)	NULL
and	NULL
PMA-activated	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
U937	NULL
cells	NULL
.	NULL

To	NULL
the	NULL
binding	NULL
reaction	NULL
,	NULL
polyclonal	NULL
antiserum	NULL
to	NULL
either	NULL
Spl	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
Sp3	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
,	NULL
or	NULL
control	NULL
preimmune	NULL
serum	NULL
(	NULL
Zanes	NULL
I	NULL
and	NULL
4	NULL
)	NULL
was	NULL
added	NULL
.	NULL

Control	NULL
reactions	NULL
containing	NULL
probe	NULL
and	NULL
preimmune	NULL
antiserum	NULL
showed	NULL
no	NULL
bands	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
2274	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
and	NULL
that	NULL
endogenous	NULL
CREB/ATF	NULL
proteins	NULL
are	NULL
necessary	NULL
for	NULL
maximal	NULL
activity	NULL
of	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
supershift	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
confirm	NULL
that	NULL
proteins	NULL
recognized	NULL
by	NULL
CREB	NULL
antiserum	NULL
(	NULL
including	NULL
ATF	NULL
,	NULL
CREB-1	NULL
,	NULL
and	NULL
CRM-1	NULL
)	NULL
bind	NULL
site	NULL
I	NULL
,	NULL
although	NULL
the	NULL
antiserum	NULL
does	NULL
not	NULL
distinguish	NULL
among	NULL
these	NULL
proteins	NULL
.	NULL

The	NULL
CREB/ATF	NULL
family	NULL
is	NULL
comprised	NULL
of	NULL
at	NULL
least	NULL
11	NULL
family	NULL
members	NULL
including	NULL
ATFI-8	NULL
,	NULL
CREB-1	NULL
,	NULL
and	NULL
CRE	NULL
modulator	NULL
(	NULL
CREM	NULL
)	NULL
;	NULL
it	NULL
contains	NULL
both	NULL
frans-ac-tivators	NULL
and	NULL
frans-dominant	NULL
negative	NULL
inhibitors	NULL
of	NULL
CRE	NULL
site-depen-dent	NULL
transcription	NULL
(	NULL
31-35	NULL
)	NULL
.	NULL

In	NULL
the	NULL
future	NULL
it	NULL
will	NULL
be	NULL
important	NULL
to	NULL
determine	NULL
which	NULL
CREB/ATF	NULL
proteins	NULL
regulate	NULL
transcription	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
in	NULL
monocytes/macrophages	NULL
and	NULL
how	NULL
monocyte/macrophage	NULL
activation	NULL
may	NULL
alter	NULL
the	NULL
abundance	NULL
and/or	NULL
activity	NULL
of	NULL
CREB/ATF	NULL
proteins	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
CREB/ATF	NULL
proteins	NULL
to	NULL
NF-IL6	NULL
promoter	NULL
activity	NULL
before	NULL
cellular	NULL
activation	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
observation	NULL
of	NULL
proteins	NULL
binding	NULL
to	NULL
site	NULL
I	NULL
before	NULL
U937	NULL
cell	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
the	NULL
observation	NULL
of	NULL
others	NULL
that	NULL
CREB/ATF	NULL
proteins	NULL
can	NULL
interact	NULL
directly	NULL
with	NULL
the	NULL
basal	NULL
transcription	NULL
machinery	NULL
(	NULL
36	NULL
)	NULL
,	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
CREB/ATF	NULL
proteins	NULL
are	NULL
known	NULL
to	NULL
regulate	NULL
the	NULL
transcription	NULL
of	NULL
other	NULL
genes	NULL
before	NULL
cellular	NULL
activation	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

CREB/ATF	NULL
proteins	NULL
are	NULL
also	NULL
important	NULL
for	NULL
PMA-inducible	NULL
transcription	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
in	NULL
monocytes	NULL
.	NULL

It	NULL
has	NULL
been	NULL
clearly	NULL
demonstrated	NULL
that	NULL
signal-dependent	NULL
kinases	NULL
phosphorylate	NULL
CREB	NULL
and	NULL
enhance	NULL
CREB-mediated	NULL
frans-activation	NULL
.	NULL

In	NULL
monocytes	NULL
we	NULL
observed	NULL
an	NULL
increase	NULL
in	NULL
transcriptional	NULL
activation	NULL
without	NULL
a	NULL
change	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
site	NULL
I	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
possibility	NULL
that	NULL
PMA	NULL
may	NULL
induce	NULL
kinases	NULL
that	NULL
activate	NULL
CREB/	NULL
ATF	NULL
proteins	NULL
(	NULL
39-41	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
CRE	NULL
site	NULL
in	NULL
cellular	NULL
activation	NULL
responsive	NULL
gene	NULL
expression	NULL
is	NULL
consistent	NULL
with	NULL
prior	NULL
observations	NULL
that	NULL
CRE	NULL
sites	NULL
are	NULL
cytokine	NULL
responsive	NULL
elements	NULL
in	NULL
the	NULL
myeloid	NULL
cell	NULL
line	NULL
TF-1	NULL
.	NULL

Treatment	NULL
of	NULL
TP-1	NULL
cells	NULL
with	NULL
GM-CSF	NULL
or	NULL
IL-3	NULL
induces	NULL
erg-	NULL
]	NULL
promoter	NULL
activity	NULL
,	NULL
which	NULL
is	NULL
dependent	NULL
upon	NULL
CRE	NULL
and	NULL
serum	NULL
response	NULL
element	NULL
(	NULL
SRE	NULL
)	NULL
sites	NULL
(	NULL
40-42	NULL
)	NULL
.	NULL

CRE	NULL
sites	NULL
have	NULL
also	NULL
been	NULL
implicated	NULL
in	NULL
monocyte	NULL
differentiation-specific	NULL
transcription	NULL
of	NULL
macrophage	NULL
inflammatory	NULL
protein-1B	NULL
(	NULL
MIP-1B	NULL
)	NULL
(	NULL
43	NULL
)	NULL
,	NULL
MuRANTES	NULL
,	NULL
and	NULL
erg-2	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
functional	NULL
role	NULL
for	NULL
the	NULL
CRE	NULL
site	NULL
in	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
NF-ZL6	NULL
gene	NULL
in	NULL
activated	NULL
U937	NULL
cells	NULL
underscores	NULL
the	NULL
important	NULL
role	NULL
played	NULL
by	NULL
CRE-binding	NULL
proteins	NULL
in	NULL
monocyte/macrophage	NULL
activation-dependent	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
-80-bp	NULL
Sp1	NULL
site	NULL
in	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
We	NULL
also	NULL
demonstrated	NULL
that	NULL
a	NULL
guanosine	NULL
and	NULL
cytosine-rich	NULL
region	NULL
recognized	NULL
by	NULL
the	NULL
Sp1	NULL
family	NULL
of	NULL
proteins	NULL
at	NULL
-80	NULL
is	NULL
important	NULL
for	NULL
basal	NULL
and	NULL
activation-induced	NULL
NF-IL6	NULL
promoter	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Factors	NULL
known	NULL
to	NULL
bind	NULL
Sp1	NULL
sites	NULL
include	NULL
SpI-4	NULL
,	NULL
and	NULL
the	NULL
Egr	NULL
family	NULL
(	NULL
45-48	NULL
)	NULL
.	NULL

Our	NULL
supershift	NULL
experiments	NULL
demonstrated	NULL
that	NULL
Sp1	NULL
,	NULL
but	NULL
not	NULL
Sp3	NULL
,	NULL
present	NULL
in	NULL
U937	NULL
cell	NULL
nuclear	NULL
extracts	NULL
binds	NULL
to	NULL
the	NULL
NF-IL6	NULL
gene	NULL
site	NULL
II	NULL
sequence	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
other	NULL
Spl	NULL
family	NULL
members	NULL
,	NULL
which	NULL
cross-react	NULL
with	NULL
the	NULL
Spl	NULL
antiserum	NULL
,	NULL
bind	NULL
site	NULL
II	NULL
.	NULL

Consistent	NULL
with	NULL
our	NULL
observations	NULL
,	NULL
guanosine	NULL
and	NULL
cytosine-rich	NULL
sequences	NULL
recognized	NULL
by	NULL
Spl	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
PMA-responsive	NULL
elements	NULL
in	NULL
other	NULL
genes	NULL
such	NULL
as	NULL
the	NULL
thromboxane	NULL
receptor	NULL
gene	NULL
(	NULL
49	NULL
)	NULL
,	NULL
proximal	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
A-chain	NULL
gene	NULL
(	NULL
50	NULL
)	NULL
,	NULL
and	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
do	NULL
not	NULL
know	NULL
how	NULL
Sp1	NULL
proteins	NULL
confer	NULL
PMA	NULL
inducibility	NULL
to	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
,	NULL
our	NULL
data	NULL
add	NULL
to	NULL
growing	NULL
evidence	NULL
that	NULL
Spl	NULL
sites	NULL
can	NULL
be	NULL
targets	NULL
of	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

The	NULL
NF-IL6	NULL
promoter	NULL
is	NULL
controlled	NULL
by	NULL
different	NULL
regulatory	NULL
elements	NULL
in	NULL
macrophages	NULL
and	NULL
hepatocytes	NULL
During	NULL
completion	NULL
of	NULL
this	NULL
work	NULL
,	NULL
a	NULL
study	NULL
analyzing	NULL
NF-ZLG6	NULL
gene	NULL
expression	NULL
during	NULL
liver	NULL
regeneration	NULL
was	NULL
reported	NULL
(	NULL
52	NULL
)	NULL
.	NULL

In	NULL
the	NULL
liver	NULL
,	NULL
REGULATION	NULL
OF	NULL
NF-IL6	NULL
IN	NULL
U937	NULL
CELLS	NULL
expression	NULL
of	NULL
NF-IL6	NULL
is	NULL
induced	NULL
at	NULL
times	NULL
of	NULL
physiologic	NULL
stress	NULL
such	NULL
as	NULL
the	NULL
acute	NULL
phase	NULL
response	NULL
and	NULL
liver	NULL
regeneration	NULL
(	NULL
53	NULL
)	NULL
.	NULL

There	NULL
are	NULL
significant	NULL
differences	NULL
in	NULL
promoter	NULL
elements	NULL
required	NULL
for	NULL
NF-IL6	NULL
transcription	NULL
in	NULL
hepatocytic	NULL
and	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
hepatocytic	NULL
lines	NULL
,	NULL
basal	NULL
and	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
PKA	NULL
)	NULL
-inducible	NULL
NF-IL6	NULL
promoter	NULL
activity	NULL
required	NULL
the	NULL
synergistic	NULL
activity	NULL
of	NULL
two	NULL
CRE	NULL
sites	NULL
,	NULL
located	NULL
at	NULL
-62	NULL
and	NULL
-110	NULL
bp	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
.	NULL

Although	NULL
our	NULL
DNase	NULL
I	NULL
footprinting	NULL
experiments	NULL
showed	NULL
that	NULL
the	NULL
-110-bp	NULL
CRE	NULL
site	NULL
was	NULL
occupied	NULL
by	NULL
U937	NULL
cell	NULL
nuclear	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
this	NULL
region	NULL
was	NULL
not	NULL
required	NULL
for	NULL
minimal	NULL
promoter	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

A	NULL
104-bp	NULL
region	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
(	NULL
-97	NULL
to	NULL
+7	NULL
bp	NULL
)	NULL
,	NULL
containing	NULL
a	NULL
functionally	NULL
important	NULL
CRE	NULL
site	NULL
at	NULL
-62	NULL
bp	NULL
and	NULL
a	NULL
functionally	NULL
important	NULL
Spl	NULL
site	NULL
at	NULL
-80	NULL
bp	NULL
,	NULL
was	NULL
sufficient	NULL
to	NULL
confer	NULL
full	NULL
promoter	NULL
activity	NULL
in	NULL
either	NULL
untreated	NULL
or	NULL
activated	NULL
U937	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
,	NULL
together	NULL
with	NULL
those	NULL
of	NULL
Nighof	NULL
et	NULL
al	NULL
.	NULL

(	NULL
52	NULL
)	NULL
,	NULL
emphasize	NULL
the	NULL
importance	NULL
of	NULL
CRE	NULL
sites	NULL
for	NULL
regulation	NULL
of	NULL
the	NULL
NF-ZL6	NULL
promoter	NULL
in	NULL
both	NULL
cell	NULL
lineages	NULL
and	NULL
show	NULL
that	NULL
the	NULL
-62-bp	NULL
CRE	NULL
site	NULL
alone	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
provide	NULL
full	NULL
promoter	NULL
activity	NULL
in	NULL
either	NULL
cell	NULL
lineage	NULL
.	NULL

In	NULL
monocytes	NULL
,	NULL
the	NULL
promoter	NULL
proximal	NULL
CRE	NULL
site	NULL
requires	NULL
the	NULL
Sp1	NULL
site	NULL
,	NULL
whereas	NULL
in	NULL
hepatocytes	NULL
an	NULL
upstream	NULL
CRE	NULL
site	NULL
is	NULL
required	NULL
.	NULL

Thus	NULL
the	NULL
NF-IL6	NULL
gene	NULL
provides	NULL
an	NULL
example	NULL
of	NULL
a	NULL
promoter	NULL
that	NULL
is	NULL
regulated	NULL
by	NULL
different	NULL
cis	NULL
elements	NULL
in	NULL
different	NULL
cell	NULL
lineages	NULL
.	NULL

Proteins	NULL
binding	NULL
to	NULL
both	NULL
CRE	NULL
and	NULL
Spl	NULL
sites	NULL
are	NULL
ubiquitously	NULL
present	NULL
;	NULL
however	NULL
,	NULL
tissue-specific	NULL
differences	NULL
in	NULL
the	NULL
relative	NULL
abundance	NULL
of	NULL
individual	NULL
family	NULL
members	NULL
,	NULL
posttranslational	NULL
modifications	NULL
or	NULL
coactivators	NULL
are	NULL
likely	NULL
to	NULL
exist	NULL
.	NULL

It	NULL
may	NULL
be	NULL
that	NULL
monocytes	NULL
have	NULL
increased	NULL
abundance	NULL
or	NULL
activity	NULL
of	NULL
proteins	NULL
that	NULL
can	NULL
activate	NULL
through	NULL
the	NULL
Sp1	NULL
site	NULL
relative	NULL
to	NULL
hepatocytes	NULL
.	NULL

This	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
Sp1	NULL
site	NULL
in	NULL
the	NULL
macrophage-specific	NULL
CD11b	NULL
promoter	NULL
is	NULL
occupied	NULL
in	NULL
a	NULL
macrophage-specific	NULL
way	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
hepatocytes	NULL
may	NULL
have	NULL
a	NULL
cellular	NULL
activity	NULL
that	NULL
functions	NULL
through	NULL
the	NULL
-110-bp	NULL
CRE	NULL
site	NULL
that	NULL
is	NULL
less	NULL
active	NULL
or	NULL
abundant	NULL
in	NULL
monocytes	NULL
.	NULL

Either	NULL
model	NULL
could	NULL
explain	NULL
why	NULL
the	NULL
promoter	NULL
proximal	NULL
CRE	NULL
site	NULL
requires	NULL
the	NULL
Spl	NULL
site	NULL
in	NULL
monocytes	NULL
while	NULL
the	NULL
upstream	NULL
CRE	NULL
site	NULL
is	NULL
required	NULL
in	NULL
hepatocytes	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
of	NULL
being	NULL
regulated	NULL
by	NULL
different	NULL
cis	NULL
elements	NULL
,	NULL
we	NULL
speculate	NULL
that	NULL
the	NULL
NF-IL6	NULL
promoter	NULL
is	NULL
subjected	NULL
to	NULL
regulation	NULL
by	NULL
different	NULL
signaling	NULL
pathways	NULL
in	NULL
hepatocytes	NULL
and	NULL
monocytes	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
the	NULL
members	NULL
of	NULL
the	NULL
Calame	NULL
laboratory	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
suggestions	NULL
during	NULL
this	NULL
work	NULL
and	NULL
Dr.	NULL
A.	NULL
Henderson	NULL
for	NULL
critically	NULL
reading	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
thank	NULL
R.	NULL
Allen	NULL
for	NULL
technical	NULL
help	NULL
with	NULL
the	NULL
DNase	NULL
I	NULL
experiments	NULL
,	NULL
Dr.	NULL
R.	NULL
Prywes	NULL
for	NULL
assistance	NULL
with	NULL
the	NULL
EMSAs	NULL
,	NULL
Dr.	NULL
X.-F.	NULL
Wang	NULL
for	NULL
supplying	NULL
oligonucleotides	NULL
and	NULL
antiserum	NULL
used	NULL
in	NULL
our	NULL
work	NULL
,	NULL
and	NULL
Y.	NULL
Lin	NULL
for	NULL
help	NULL
with	NULL
the	NULL
figures	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr.	NULL
V.	NULL
Poli	NULL
for	NULL
the	NULL
murine	NULL
NF-IL6	NULL
genomic	NULL
clone	NULL
,	NULL
Dr.	NULL
Denong	NULL
Wong	NULL
for	NULL
supplying	NULL
the	NULL
Gag	NULL
antiserum	NULL
,	NULL
Dr.	NULL
R.	NULL
Dalla-Favera	NULL
for	NULL
the	NULL
human	NULL
B-actin	NULL
construct	NULL
,	NULL
and	NULL
Dr.	NULL
J.Lei-den	NULL
for	NULL
the	NULL
CREB-2	NULL
plasmid	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Henderson	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
Connor	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1996	NULL
.	NULL

C/EBP	NULL
activators	NULL
are	NULL
required	NULL
for	NULL
HIV-1	NULL
replication	NULL
and	NULL
proviral	NULL
induction	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

Immunity	NULL
5:91	NULL
.	NULL

2	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
T.	NULL
Sugita	NULL
,	NULL
T.	NULL
Osamu	NULL
,	NULL
S.	NULL
Kinoshita	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
T.	NULL
Nakajima	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
for	NULL
IL-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:1897	NULL
.	NULL

3	NULL
.	NULL

Matsusaka	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Fujikawa	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
K.	NULL
Matsushima	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
factors	NULL
NFB-IL6	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
syn-ergistically	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
interleukin	NULL
6	NULL
and	NULL
interleukin	NULL
8	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:10193	NULL
.	NULL

4	NULL
.	NULL

Natsuka	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
S.	NULL
Hashimoto	NULL
,	NULL
T.	NULL
Sugita	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

Macrophage	NULL
differentiation-specific	NULL
expression	NULL
of	NULL
NF-IL6	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
for	NULL
Interleukin-6	NULL
.	NULL

Blood	NULL
79:460	NULL
.	NULL

5	NULL
.	NULL

Dunn	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
L.	NULL
S.	NULL
Coles	NULL
,	NULL
R.	NULL
K.	NULL
Lang	NULL
,	NULL
S.	NULL
Gerondakis	NULL
,	NULL
M.	NULL
A.	NULL
Vadas	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Shannon	NULL
.	NULL

1994	NULL
.	NULL

Requirement	NULL
for	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-	NULL
«	NULL
kB	NULL
p65	NULL
and	NULL
NF-interleukin-6	NULL
binding	NULL
elements	NULL
in	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
response	NULL
region	NULL
of	NULL
the	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
.	NULL

Blood	NULL
83:2469	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
6	NULL
.	NULL

7	NULL
.	NULL

8	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

Pope	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
A.	NULL
Leutz	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Ness	NULL
.	NULL

1994	NULL
.	NULL

C/EBP	NULL
§	NULL
regulation	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

94:1449	NULL
.	NULL

Henderson	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1997	NULL
.	NULL

C/EBP	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
HIV-1	NULL
replication	NULL
in	NULL
monocyte/macrophages	NULL
but	NULL
not	NULL
T-cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:8714	NULL
.	NULL

Tanaka	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
M.	NULL
Umemoto	NULL
,	NULL
Y.	NULL
Yoneda	NULL
,	NULL
N.	NULL
Shirafuji	NULL
,	NULL
H.	NULL
Fujiwara	NULL
,	NULL
S.	NULL
Suematsu	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1995	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
NE-IL6	NULL
gene	NULL
discloses	NULL
its	NULL
essential	NULL
role	NULL
in	NULL
bacteria	NULL
killing	NULL
and	NULL
tumor	NULL
cytotox-icity	NULL
by	NULL
macrophages	NULL
.	NULL

Cell	NULL
80:353.	NULL
.	NULL

Screpanti	NULL
,	NULL
I.	NULL
,	NULL
L.	NULL
Romani	NULL
,	NULL
P.	NULL
Musiani	NULL
,	NULL
A.	NULL
Modesti	NULL
,	NULL
E.	NULL
Fattori	NULL
,	NULL
D.	NULL
Lazzaro	NULL
,	NULL
C.	NULL
Sellito	NULL
,	NULL
S.	NULL
Scarpa	NULL
,	NULL
D.	NULL
Bellavia	NULL
,	NULL
G.	NULL
Lattanzio	NULL
.	NULL

1995	NULL
.	NULL

Lymphoproliferative	NULL
disorder	NULL
and	NULL
imbalanced	NULL
T	NULL
helper	NULL
response	NULL
in	NULL
C/EBPB-deficient	NULL
mice	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:1932	NULL
.	NULL

Screpanti	NULL
,	NULL
I.	NULL
,	NULL
P.	NULL
Musiani	NULL
,	NULL
D.	NULL
Bellavia	NULL
,	NULL
M.	NULL
Cappelletti	NULL
,	NULL
F.	NULL
B.	NULL
Aiello	NULL
,	NULL
M.	NULL
Maroder	NULL
,	NULL
L.	NULL
Frati	NULL
,	NULL
A.	NULL
Modesti	NULL
,	NULL
A.	NULL
Gulino	NULL
,	NULL
and	NULL
V.	NULL
Poli	NULL
.	NULL

1996	NULL
.	NULL

Inactivation	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
prevents	NULL
development	NULL
of	NULL
multicentric	NULL
Castleman	NULL
's	NULL
disease	NULL
in	NULL
C/EBP	NULL
B-deficient	NULL
mice	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:1561.	NULL
Cooper	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Berrier	NULL
,	NULL
C.	NULL
Roman	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1994	NULL
.	NULL

Limited	NULL
expression	NULL
of	NULL
C/EBP	NULL
family	NULL
proteins	NULL
during	NULL
B-lymphocyte	NULL
development	NULL
:	NULL
negative	NULL
regulator	NULL
Ig/EBP	NULL
predominates	NULL
early	NULL
and	NULL
activator	NULL
NF-IL6	NULL
is	NULL
induced	NULL
later	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:5049	NULL
.	NULL

Manchado	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
Yubero	NULL
,	NULL
O.	NULL
Vinas	NULL
,	NULL
R.	NULL
Iglesias	NULL
,	NULL
F.	NULL
Villarroya	NULL
,	NULL
T.	NULL
Mampel	NULL
,	NULL
and	NULL
M.	NULL
Giralt	NULL
.	NULL

1994	NULL
.	NULL

CCAAT/enhancer-binding	NULL
proteins	NULL
a	NULL
and	NULL
B	NULL
in	NULL
brown	NULL
adipose	NULL
tissue	NULL
:	NULL
evidence	NULL
for	NULL
a	NULL
tissue-specific	NULL
pattern	NULL
of	NULL
expression	NULL
during	NULL
development	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

302:695	NULL
.	NULL

Nilsson	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Forsbeck	NULL
,	NULL
M.	NULL
Gidlund	NULL
,	NULL
C.	NULL
Sundstrom	NULL
,	NULL
T.	NULL
Totterman	NULL
,	NULL
J.	NULL
Sallstrom	NULL
,	NULL
and	NULL
P.	NULL
Venge	NULL
.	NULL

1981	NULL
.	NULL

Surface	NULL
characteristics	NULL
of	NULL
the	NULL
U-937	NULL
human	NULL
histiocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
:	NULL
specific	NULL
changes	NULL
during	NULL
inducible	NULL
morphologic	NULL
and	NULL
functional	NULL
differentiation	NULL
in	NULL
vitro	NULL
.	NULL

Hamatol	NULL
.	NULL

Bluttransfus	NULL
.	NULL

26:215	NULL
.	NULL

Krumm	NULL
,	NULL
A.	NULL
,	NULL
T.	NULL
Meulia	NULL
,	NULL
M.	NULL
Brunvand	NULL
,	NULL
and	NULL
M.	NULL
Groudine	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
block	NULL
to	NULL
transcriptional	NULL
elongation	NULL
within	NULL
the	NULL
human	NULL
c-myc	NULL
gene	NULL
is	NULL
determined	NULL
in	NULL
the	NULL
promoter-proximal	NULL
region	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:2201	NULL
.	NULL

Quinn	NULL
,	NULL
P.	NULL
G.	NULL
1993	NULL
.	NULL

Distinct	NULL
activation	NULL
domains	NULL
within	NULL
cAMP	NULL
response	NULL
element-binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
mediate	NULL
basal	NULL
and	NULL
cAMP-stimulated	NULL
transcription	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:16999	NULL
.	NULL

Brasier	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
J.	NULL
E.	NULL
Tate	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Habener	NULL
.	NULL

1989	NULL
.	NULL

Optimized	NULL
use	NULL
of	NULL
the	NULL
firefly	NULL
luciferase	NULL
assay	NULL
as	NULL
a	NULL
reporter	NULL
gene	NULL
in	NULL
mammalian	NULL
cell	NULL
lines	NULL
.	NULL

Biotechniques	NULL
7:1116	NULL
.	NULL

Chirgwin	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
A.	NULL
E.	NULL
Przbyla	NULL
,	NULL
R.	NULL
J.	NULL
MacDonald	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Rutter	NULL
.	NULL

1979	NULL
.	NULL

Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonucle-ase	NULL
.	NULL

Biochemistry	NULL
18:5294	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Plainview	NULL
,	NULL
NY	NULL
.	NULL

Feinberg	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
and	NULL
B.	NULL
Vogelstein	NULL
.	NULL

1983	NULL
.	NULL

A	NULL
technique	NULL
for	NULL
radiolabeling	NULL
DNA	NULL
restriction	NULL
endonuclease	NULL
fragments	NULL
to	NULL
high	NULL
specific	NULL
activity	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

132:6	NULL
.	NULL

Duncan	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
A.	NULL
Stupakoff	NULL
,	NULL
S.	NULL
M.	NULL
Hedrick	NULL
,	NULL
K.	NULL
B.	NULL
Marcu	NULL
,	NULL
and	NULL
G.	NULL
Siu	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
myc-associated	NULL
zinc	NULL
finger	NULL
protein	NULL
binding	NULL
site	NULL
is	NULL
one	NULL
of	NULL
four	NULL
important	NULL
functional	NULL
regions	NULL
in	NULL
the	NULL
CD4	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:3179	NULL
.	NULL

Parker	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
and	NULL
J.	NULL
Topol	NULL
.	NULL

1984	NULL
.	NULL

A	NULL
drosophila	NULL
RNA	NULL
polymerase	NULL
II	NULL
transcription	NULL
factor	NULL
contains	NULL
a	NULL
promoter-region-specific	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Cell	NULL
36:357	NULL
.	NULL

Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
E.	NULL
Schreiber	NULL
,	NULL
W.	NULL
Schaffner	NULL
,	NULL
and	NULL
P.	NULL
Matthias	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
test	NULL
for	NULL
in	NULL
vivo	NULL
stability	NULL
and	NULL
DNA	NULL
binding	NULL
of	NULL
mutated	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
``	NULL
mini-extracts	NULL
``	NULL
prepared	NULL
from	NULL
transfected	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6420	NULL
.	NULL

Einat	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Resnitzky	NULL
,	NULL
and	NULL
A.	NULL
Kimchi	NULL
.	NULL

1985	NULL
.	NULL

Close	NULL
link	NULL
between	NULL
reduction	NULL
of	NULL
c-myc	NULL
expression	NULL
by	NULL
interferon	NULL
and	NULL
GO/G1	NULL
arrest	NULL
.	NULL

Nature	NULL
313:597	NULL
.	NULL

Chang	NULL
,	NULL
C.-J	NULL
.	NULL

,	NULL
T.-T.	NULL
Chen	NULL
,	NULL
H.-Y	NULL
.	NULL

Lei	NULL
,	NULL
D.-S.	NULL
Chen	NULL
,	NULL
and	NULL
S.-C.	NULL
Lee	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
,	NULL
AGP-EBP	NULL
,	NULL
that	NULL
belongs	NULL
to	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:6642	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
P.	NULL
Mitchell	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

Purified	NULL
transcription	NULL
factor	NULL
AP-1	NULL
interacts	NULL
with	NULL
TPA-inducible	NULL
enhancer	NULL
elements	NULL
.	NULL

Cell	NULL
49:741	NULL
.	NULL

Lin	NULL
,	NULL
Y.	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1988	NULL
.	NULL

Interaction	NULL
of	NULL
a	NULL
common	NULL
transcription	NULL
factor	NULL
,	NULL
ATF	NULL
,	NULL
with	NULL
regulatory	NULL
elements	NULL
in	NULL
both	NULL
Ela	NULL
and	NULL
cyclic	NULL
AMP-inducible	NULL
promoters	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:3396	NULL
.	NULL

Dynan	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1983	NULL
.	NULL

The	NULL
promoter-specific	NULL
transcription	NULL
factor	NULL
Spl	NULL
binds	NULL
to	NULL
upstream	NULL
sequences	NULL
in	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
.	NULL

Cell	NULL
35:79	NULL
.	NULL

Datto	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Y.	NULL
Yu	NULL
,	NULL
and	NULL
X.-F.	NULL
Wang	NULL
.	NULL

1995	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
transforming	NULL
growth	NULL
factor	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:28623	NULL
.	NULL

Udvadia	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
K.	NULL
T.	NULL
Rogers	NULL
,	NULL
P.	NULL
D.	NULL
R.	NULL
Higgins	NULL
,	NULL
Y.	NULL
Murata	NULL
,	NULL
K.	NULL
Martin	NULL
,	NULL
P.	NULL
A.	NULL
Humphrey	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Horowitz	NULL
.	NULL

1993	NULL
.	NULL

Sp-1	NULL
binds	NULL
promoter	NULL
elements	NULL
regulated	NULL
by	NULL
the	NULL
RB	NULL
protein	NULL
and	NULL
Sp-1-mediated	NULL
transcription	NULL
is	NULL
stimulated	NULL
by	NULL
RB	NULL
coexpression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:32635	NULL
.	NULL

Udvadia	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
J.	NULL
Templeton	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Horowitz	NULL
.	NULL

1995	NULL
.	NULL

Functional	NULL
interactions	NULL
between	NULL
the	NULL
retinoblastoma	NULL
(	NULL
Rb	NULL
)	NULL
protein	NULL
and	NULL
Sp-family	NULL
members	NULL
:	NULL
superactivation	NULL
by	NULL
Rb	NULL
requires	NULL
amino	NULL
acids	NULL
necessary	NULL
for	NULL
growth	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:3953	NULL
.	NULL

Karpinski	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
G.	NULL
D.	NULL
Morle	NULL
,	NULL
J.	NULL
Huggenvik	NULL
,	NULL
M.	NULL
D.	NULL
Uhler	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
human	NULL
CREB-2	NULL
:	NULL
an	NULL
ATE/CREB	NULL
transcription	NULL
factor	NULL
32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

2275	NULL
that	NULL
can	NULL
negatively	NULL
regulate	NULL
transcription	NULL
from	NULL
the	NULL
cAMP	NULL
response	NULL
element	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:4820	NULL
.	NULL

Ziff	NULL
,	NULL
E.	NULL
B	NULL
.	NULL

1990	NULL
.	NULL

Transcription	NULL
factors	NULL
:	NULL
a	NULL
new	NULL
family	NULL
gathers	NULL
at	NULL
the	NULL
cAMP	NULL
response	NULL
site	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

6:69	NULL
.	NULL

Hai	NULL
,	NULL
T.	NULL
,	NULL
F.	NULL
Liu	NULL
,	NULL
W.	NULL
J.	NULL
Coukos	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1989	NULL
.	NULL

Transcription	NULL
factor	NULL
ATF	NULL
cDNA	NULL
clones	NULL
:	NULL
an	NULL
extensive	NULL
family	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
able	NULL
to	NULL
selectively	NULL
form	NULL
DNA-binding	NULL
heterodimers	NULL
.	NULL

Genes	NULL
Dev	NULL
,	NULL
3:2083	NULL
.	NULL

Hoeffler	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
T.	NULL
E.	NULL
Meyer	NULL
,	NULL
Y.	NULL
Yun	NULL
,	NULL
J.	NULL
L.	NULL
Jameson	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Habener	NULL
.	NULL

1988	NULL
.	NULL

Cyclic	NULL
AMP-responsive	NULL
DNA-binding	NULL
protein	NULL
:	NULL
structure	NULL
based	NULL
on	NULL
a	NULL
cloned	NULL
placental	NULL
cDNA	NULL
.	NULL

Science	NULL
242:1430	NULL
.	NULL

Foulkes	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
E.	NULL
Borrelli	NULL
,	NULL
and	NULL
P.	NULL
Sassone-Corsi	NULL
.	NULL

1991	NULL
.	NULL

CREM	NULL
gene	NULL
:	NULL
use	NULL
of	NULL
alternative	NULL
DNA-binding	NULL
domains	NULL
generates	NULL
multiple	NULL
antagonists	NULL
of	NULL
cAMP-in-duced	NULL
transcription	NULL
.	NULL

Cell	NULL
64:739	NULL
.	NULL

Xing	NULL
,	NULL
L.	NULL
,	NULL
V.	NULL
K.	NULL
Gopal	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Quinn	NULL
.	NULL

1995.	NULL
cAMP	NULL
response	NULL
element	NULL
binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
interacts	NULL
with	NULL
transcription	NULL
factor	NULL
IIB	NULL
and	NULL
IID	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:17488	NULL
.	NULL

Xing	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Quinn	NULL
.	NULL

1993	NULL
.	NULL

Involvement	NULL
of	NULL
3	NULL
'	NULL
5'-cAMP	NULL
regulatory	NULL
element	NULL
binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
in	NULL
both	NULL
basal	NULL
and	NULL
hormone	NULL
mediated	NULL
expression	NULL
of	NULL
the	NULL
phosphoenolpyruvate	NULL
carboxykinase	NULL
(	NULL
PEPCK	NULL
)	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

7:1484	NULL
.	NULL

Kim	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
M.	NULL
K.	NULL
Lee	NULL
,	NULL
J.	NULL
Carroll	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Joh	NULL
.	NULL

1993	NULL
.	NULL

Both	NULL
the	NULL
basal	NULL
and	NULL
inducible	NULL
transcription	NULL
of	NULL
the	NULL
tyrosine	NULL
hydroxylase	NULL
gene	NULL
are	NULL
dependent	NULL
upon	NULL
a	NULL
cAMP	NULL
response	NULL
clement	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:15689	NULL
.	NULL

Chrivia	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
R.	NULL
P.	NULL
S.	NULL
Kwok	NULL
,	NULL
N.	NULL
Lamb	NULL
,	NULL
M.	NULL
Hagiwara	NULL
,	NULL
M.	NULL
R.	NULL
Montminy	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Goodman	NULL
.	NULL

1993	NULL
.	NULL

Phosphorylated	NULL
CREB	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
nuclear	NULL
protein	NULL
CBP	NULL
.	NULL

Nature	NULL
365:855	NULL
.	NULL

Sakamoto	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
J.	NULL
K.	NULL
Fraser	NULL
,	NULL
H.	NULL
J.	NULL
Lee	NULL
,	NULL
E.	NULL
Lehman	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Gasson	NULL
.	NULL

1994	NULL
.	NULL

Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
interleukin-3	NULL
signaling	NULL
pathways	NULL
converge	NULL
on	NULL
the	NULL
CREB-binding	NULL
site	NULL
in	NULL
the	NULL
human	NULL
egr-1	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:5975	NULL
.	NULL

Lee	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
R.	NULL
C.	NULL
Mignacca	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Sakamoto	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
egr-1	NULL
by	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
but	NULL
not	NULL
interleukin	NULL
3	NULL
requires	NULL
phosphorylation	NULL
of	NULL
cAMP	NULL
response	NULL
element-binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
on	NULL
serine	NULL
133	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:15979	NULL
.	NULL

Mignacca	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
H.	NULL
J.	NULL
Lee	NULL
,	NULL
E.	NULL
M.	NULL
Kwon	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Sakamoto	NULL
.	NULL

1996	NULL
.	NULL

Mechanism	NULL
of	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
immediate	NULL
early	NULL
gene	NULL
Egr-1	NULL
in	NULL
response	NULL
to	NULL
PIXY321	NULL
.	NULL

Blood	NULL
88:848	NULL
.	NULL

Proffitt	NULL
,	NULL
J.	NULL
,	NULL
G.	NULL
Crabtree	NULL
,	NULL
M.	NULL
Grove	NULL
,	NULL
P.	NULL
Daubersies	NULL
,	NULL
B.	NULL
Bailleul	NULL
,	NULL
E.	NULL
Wright	NULL
,	NULL
and	NULL
M.	NULL
Plumb	NULL
.	NULL

1995	NULL
.	NULL

An	NULL
ATE/CREB-binding	NULL
site	NULL
is	NULL
essential	NULL
for	NULL
cell-specific	NULL
and	NULL
inducible	NULL
transcription	NULL
of	NULL
the	NULL
murine	NULL
B	NULL
cytokine	NULL
gene	NULL
.	NULL

Gene	NULL
152:173	NULL
.	NULL

Shin	NULL
,	NULL
H.	NULL
S.	NULL
,	NULL
B.	NULL
E.	NULL
Drysdale	NULL
,	NULL
M.	NULL
L.	NULL
Shin	NULL
,	NULL
P.	NULL
W.	NULL
Noble	NULL
,	NULL
S.	NULL
N.	NULL
Fisher	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Paznekas	NULL
.	NULL

1994	NULL
.	NULL

Definition	NULL
of	NULL
a	NULL
lipopolysaccharide-responsive	NULL
element	NULL
in	NULL
the	NULL
5'-flanking	NULL
regions	NULL
of	NULL
MuRantes	NULL
and	NULL
crg-2	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:2914	NULL
.	NULL

Hagen	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Muller	NULL
,	NULL
M.	NULL
Beato	NULL
,	NULL
and	NULL
G.	NULL
Suske	NULL
.	NULL

1992	NULL
.	NULL

Cloning	NULL
by	NULL
recognition	NULL
site	NULL
screening	NULL
of	NULL
two	NULL
novel	NULL
GT	NULL
box	NULL
binding	NULL
proteins	NULL
:	NULL
a	NULL
family	NULL
of	NULL
Sp1	NULL
related	NULL
genes	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:5519	NULL
.	NULL

Kharbanda	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Nakamura	NULL
,	NULL
R.	NULL
Stonc	NULL
,	NULL
R.	NULL
Hass	NULL
,	NULL
S.	NULL
Bernstein	NULL
,	NULL
R.	NULL
Datta	NULL
,	NULL
V.	NULL
P.	NULL
Sukhatme	NULL
,	NULL
and	NULL
D.	NULL
Kufe	NULL
.	NULL

1991	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
early	NULL
growth	NULL
response	NULL
1	NULL
and	NULL
2	NULL
zinc	NULL
finger	NULL
genes	NULL
during	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88:571	NULL
.	NULL

Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
X.	NULL
M.	NULL
Cao	NULL
,	NULL
L.	NULL
C.	NULL
Chang	NULL
,	NULL
C.	NULL
H.	NULL
Tsai-Morris	NULL
,	NULL
D.	NULL
Stamenkovich	NULL
,	NULL
P.	NULL
C.	NULL
Ferreira	NULL
,	NULL
D.	NULL
R.	NULL
Cohen	NULL
,	NULL
S.	NULL
A.	NULL
Edwards	NULL
,	NULL
T.	NULL
B	NULL
.	NULL

Shows	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
M.	NULL
M.	NULL
Le	NULL
Beau	NULL
,	NULL
and	NULL
E.	NULL
D.	NULL
Adamson	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
zinc	NULL
finger-encoding	NULL
gene	NULL
coregu-lated	NULL
with	NULL
c-fos	NULL
during	NULL
growth	NULL
and	NULL
differentiation	NULL
,	NULL
and	NULL
after	NULL
cellular	NULL
depolariza-tion	NULL
.	NULL

Cell	NULL
53:37	NULL
.	NULL

Kingsley	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
A.	NULL
Winoto	NULL
.	NULL

1992	NULL
.	NULL

Cloning	NULL
of	NULL
GT	NULL
box-binding	NULL
proteins	NULL
:	NULL
a	NULL
novel	NULL
Sp1	NULL
multigene	NULL
family	NULL
regulating	NULL
T-cell	NULL
receptor	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4251	NULL
.	NULL

D'Angelo	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
B.	NULL
G.	NULL
Oliver	NULL
,	NULL
M.	NULL
G.	NULL
Davis	NULL
,	NULL
T.	NULL
S.	NULL
McCluskey	NULL
,	NULL
and	NULL
G.	NULL
Dorn	NULL
IL	NULL
.	NULL

1996	NULL
.	NULL

Novel	NULL
role	NULL
for	NULL
Sp1	NULL
in	NULL
phorbol	NULL
ester	NULL
enhancement	NULL
of	NULL
human	NULL
platelet	NULL
thromboxane	NULL
receptor	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:19696	NULL
.	NULL

Khachigian	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
A.	NULL
J.	NULL
Williams	NULL
,	NULL
and	NULL
T.	NULL
Collins	NULL
.	NULL

1995	NULL
.	NULL

Interplay	NULL
of	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
in	NULL
the	NULL
proximal	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
A-chain	NULL
promoter	NULL
in	NULL
cultured	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:27679	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
N.	NULL
L.	NULL
Edwards	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Agranoff	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
cooperative	NULL
interaction	NULL
between	NULL
NF-KB	NULL
and	NULL
Sp1	NULL
is	NULL
required	NULL
for	NULL
HIV-1	NULL
enhancer	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3551	NULL
.	NULL

Nichof	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
P.	NULL
Manns	NULL
,	NULL
and	NULL
C.	NULL
Trautwein	NULL
.	NULL

1997	NULL
.	NULL

CREB	NULL
controls	NULL
LAP/C/EBP	NULL
transcription	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:3600	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

IL-6	NULL
and	NULL
NF-IL6	NULL
in	NULL
acute-phase	NULL
response	NULL
and	NULL
viral	NULL
infection	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

127:25	NULL
.	NULL

Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
H.	NULL
L.	NULL
Pahl	NULL
,	NULL
R.	NULL
J.	NULL
Scheibe	NULL
,	NULL
D.	NULL
E.	NULL
Zhang	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Tenen	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
Sp1	NULL
transcription	NULL
factor	NULL
binds	NULL
the	NULL
CD11b	NULL
promoter	NULL
specifically	NULL
in	NULL
myeloid	NULL
cells	NULL
in	NULL
vivo	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
myeloid-specific	NULL
promoter	NULL
activity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:8230	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

